data_1wqu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wqu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 33.2 m-70 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.434 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.484 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 2.3 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 48' ' ' GLU . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 46' ' ' LYS . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.416 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 43.5 m-70 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 10.4 t . . . . . 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.437 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 47.0 m-70 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.501 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 29.9 p . . . . . 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' H ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 44.0 m-70 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.562 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 20.3 p . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.441 0.162 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.132 0.491 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.443 HH21 ' CE1' ' A' ' 61' ' ' HIS . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.443 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.416 ' CE1' HD11 ' A' ' 31' ' ' LEU . 74.2 m-70 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 20' ' ' HIS . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 12.6 t . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.474 HD21 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 14' ' ' HIS . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' H ' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' NE2' ' H ' ' A' ' 47' ' ' GLN 0.256 0.4 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.407 ' CD2' ' HA ' ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 HD11 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.518 0.675 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.495 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 12.2 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 29.5 m-70 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.493 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.493 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 3.2 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 7.3 t . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.463 0.217 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HE ' ' H ' ' A' ' 73' ' ' LEU . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' H ' ' HE ' ' A' ' 72' ' ' ARG . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 pm0 . . . . . 0 C--O 1.226 -0.171 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.01 175.32 14.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.716 0.758 . . . . 0.0 109.173 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -155.49 178.95 9.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 129.51 3.124 . . . . 0.0 106.213 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.96 21.27 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.315 1.436 . . . . 0.0 109.944 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -146.91 121.93 10.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.3 t -149.02 176.77 10.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.755 1.622 . . . . 0.0 109.58 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.61 75.43 1.83 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.005 0.922 . . . . 0.0 112.292 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 33.2 m-70 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.434 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.484 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 2.3 p -58.18 -43.02 87.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.82 175.51 29.84 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.15 -1.31 6.9 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.105 2.537 . . . . 0.0 113.73 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -59.51 -42.53 92.4 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.583 1.953 . . . . 0.0 113.221 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -154.92 162.92 40.95 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.525 1.53 . . . . 0.0 108.268 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.899 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -66.94 160.12 27.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 m -79.1 168.91 18.96 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.643 -0.661 . . . . 0.0 110.173 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.31 104.2 0.18 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -155.95 170.25 22.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.536 2.335 . . . . 0.0 107.836 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -138.01 112.66 8.88 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.219 1.007 . . . . 0.0 108.785 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.57 94.18 0.79 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -14.74 63.21 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 121.542 -0.975 . . . . 0.0 110.499 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 48' ' ' GLU . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 46' ' ' LYS . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.416 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t -56.54 -48.18 77.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.82 151.77 5.93 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.06 62.19 7.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.918 3.079 . . . . 0.0 111.478 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 t -72.95 139.83 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.219 -0.926 . . . . 0.0 110.026 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.8 m -74.04 -22.64 59.48 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.944 0.497 . . . . 0.0 111.106 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -151.59 156.13 39.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -72.38 111.64 7.75 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.02 42.23 2.96 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 t -154.29 167.77 28.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.209 1.803 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -120.98 11.82 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.433 2.293 . . . . 0.0 109.188 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.87 103.85 2.9 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -57.58 -30.4 65.25 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.127 0.964 . . . . 0.0 112.013 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 43.5 m-70 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 10.4 t -58.0 -52.8 64.0 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.39 -149.67 49.91 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.23 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.2 134.69 29.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.989 2.459 . . . . 0.0 111.391 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 p -132.49 141.67 48.88 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.67 1.988 . . . . 0.0 107.359 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 m -83.51 -11.37 57.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.474 0.579 . . . . 0.0 111.648 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 C-N-CA 129.212 3.291 . . . . 0.0 105.381 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.742 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.6 80.64 1.74 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.776 0.83 . . . . 0.0 111.333 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 t -145.31 -177.38 5.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.567 1.547 . . . . 0.0 107.489 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.22 -144.49 8.71 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 120.996 -1.065 . . . . 0.0 111.833 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -70.29 88.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 108.607 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -142.02 154.2 44.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.984 0.914 . . . . 0.0 109.115 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.68 78.68 1.89 Allowed Glycine 0 C--N 1.331 0.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.75 -33.28 34.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.51 1.524 . . . . 0.0 111.308 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.437 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -67.06 -49.23 65.8 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 149.82 -167.85 29.92 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.7 13.66 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.224 3.283 . . . . 0.0 114.228 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 p -58.03 168.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.942 1.697 . . . . 0.0 113.456 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -71.0 162.17 29.88 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.734 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -173.76 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -143.82 153.83 42.77 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.74 154.0 25.65 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -80.54 -172.98 3.86 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.586 2.354 . . . . 0.0 112.541 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -132.11 135.22 46.26 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.048 1.739 . . . . 0.0 106.487 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.83 81.22 1.24 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 106.051 -2.819 . . . . 0.0 106.051 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -48.69 -36.71 16.76 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.73 2.012 . . . . 0.0 113.273 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 47.0 m-70 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.501 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 29.9 p -72.11 -31.02 65.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.82 -174.98 13.71 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.311 1.91 . . . . 0.0 111.003 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.49 162.11 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.513 2.808 . . . . 0.0 113.749 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -158.92 155.18 27.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.484 1.114 . . . . 0.0 109.758 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -82.74 -67.13 0.81 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 110.429 179.398 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -140.25 166.14 25.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.48 0.712 . . . . 0.0 111.284 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -108.46 -151.6 0.47 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.795 2.038 . . . . 0.0 110.235 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.96 -21.89 37.25 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 125.005 1.288 . . . . 0.0 113.827 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -100.14 117.89 35.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.869 1.268 . . . . 0.0 113.031 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -133.55 179.96 5.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.019 1.728 . . . . 0.0 107.591 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.09 12.33 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.954 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -52.04 -33.94 40.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.802 1.241 . . . . 0.0 113.347 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' H ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p -56.62 -54.96 39.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.72 150.48 7.37 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.88 -14.14 21.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 114.686 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.9 m -61.95 -23.12 66.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -135.42 18.15 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.52 1.128 . . . . 0.0 110.899 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -79.51 15.18 1.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -55.84 162.95 1.59 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.49 76.82 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -98.82 103.1 15.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -149.85 163.28 38.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.02 113.45 3.98 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 104.561 -3.416 . . . . 0.0 104.561 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -46.83 -37.57 8.92 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.62 2.368 . . . . 0.0 112.465 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.72 -16.63 29.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.89 115.38 3.16 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.681 -1.066 . . . . 0.0 112.623 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.57 -3.56 11.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.04 3.827 . . . . 0.0 113.544 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.8 t -61.83 -28.08 69.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.46 1.027 . . . . 0.0 109.617 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -55.04 102.72 0.07 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.718 2.407 . . . . 0.0 109.859 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 C-N-CA 125.29 1.424 . . . . 0.0 110.701 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -166.68 164.98 16.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.366 1.867 . . . . 0.0 106.208 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -75.45 -169.58 1.04 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.598 0.759 . . . . 0.0 109.548 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.98 -146.88 18.05 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 120.828 -1.17 . . . . 0.0 114.765 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 t -149.8 85.95 1.44 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.752 1.221 . . . . 0.0 109.074 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -62.16 -27.78 69.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.493 0.717 . . . . 0.0 112.905 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.22 142.91 6.21 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 106.604 -2.599 . . . . 0.0 106.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.67 -48.11 75.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t -101.0 -34.73 9.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.38 -119.99 5.7 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 118.081 1.992 . . . . 0.0 118.081 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.26 38.43 0.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 1 C-N-CA 126.553 4.835 . . . . 0.0 116.298 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -57.34 -36.28 70.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.542 1.137 . . . . 0.0 111.598 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -132.51 -175.8 3.88 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.293 1.437 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.811 0 CA-C-O 117.013 -1.993 . . . . 0.0 109.701 -179.562 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 p -61.04 4.27 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.981 2.912 . . . . 0.0 115.883 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.5 154.49 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.528 1.058 . . . . 0.0 111.861 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.95 -173.47 44.97 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -145.6 -170.32 3.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 109.522 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -135.27 12.59 3.54 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.372 -0.83 . . . . 0.0 112.153 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.28 82.15 0.16 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -52.03 -50.63 61.04 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.756 1.223 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 44.0 m-70 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.562 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 20.3 p -76.13 -25.98 55.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.19 -168.11 22.59 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.107 0.384 . . . . 0.0 112.174 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.4 15.89 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.742 3.628 . . . . 0.0 114.222 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.4 t -127.72 81.04 2.0 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.12 1.368 . . . . 0.0 108.314 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 t -91.76 116.33 28.81 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.865 -179.795 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 m -169.98 162.14 9.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.612 1.965 . . . . 0.0 107.764 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.6 m -104.67 -90.59 0.39 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.133 0.973 . . . . 0.0 108.993 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.01 20.37 0.21 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.552 1.072 . . . . 0.0 112.85 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -51.28 104.42 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.547 1.539 . . . . 0.0 113.49 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t -157.94 110.72 2.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.229 1.012 . . . . 0.0 109.615 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.78 65.38 0.76 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.14 1.353 . . . . 0.0 112.579 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.98 -33.61 72.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.755 0.778 . . . . 0.0 110.992 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p -79.25 -25.25 42.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.81 169.32 12.74 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.612 1.577 . . . . 0.0 109.967 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.43 10.45 3.26 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.595 2.863 . . . . 0.0 113.559 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 -20.23 63.16 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.817 -1.177 . . . . 0.0 111.942 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -140.97 73.49 1.42 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -132.43 64.62 1.6 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 117.616 0.708 . . . . 0.0 109.93 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t -75.53 96.74 3.56 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 102.597 -3.112 . . . . 0.0 102.597 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.57 72.03 0.36 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -140.19 154.16 46.84 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.899 1.68 . . . . 0.0 107.352 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 p -120.35 -173.74 2.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.85 61.11 4.85 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.885 1.707 . . . . 0.0 111.8 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.62 -31.47 66.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.448 0.699 . . . . 0.0 111.727 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t -74.58 -30.62 61.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.74 147.91 35.98 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.48 87.14 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.577 3.518 . . . . 0.0 110.591 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -51.69 149.58 4.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.662 1.185 . . . . 0.0 107.821 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.1 m 79.43 11.49 1.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.0 110.65 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 C-N-CA 129.239 3.304 . . . . 0.0 106.946 178.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -101.32 117.4 34.9 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.949 2.1 . . . . 0.0 106.404 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -147.83 143.63 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.571 1.148 . . . . 0.0 109.275 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.32 106.42 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -148.24 20.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.267 1.034 . . . . 0.0 111.924 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -71.54 -174.67 1.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.718 0.69 . . . . 0.0 109.938 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 96.02 0.99 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 103.537 -3.825 . . . . 0.0 103.537 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -31.68 51.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.589 0.695 . . . . 0.0 112.638 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p -75.85 -38.02 58.42 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.12 -179.38 31.12 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.588 1.09 . . . . 0.0 112.316 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -80.49 44.51 1.75 Allowed 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.064 4.509 . . . . 0.0 112.795 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -97.71 153.38 18.28 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.827 -1.17 . . . . 0.0 113.078 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.2 m -150.87 152.06 33.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.013 2.125 . . . . 0.0 106.971 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.104 -1.387 . . . . 0.0 110.634 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.187 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -116.72 -83.65 0.63 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -70.86 -5.48 30.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.932 1.242 . . . . 0.0 112.289 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.34 3.01 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.932 1.729 . . . . 0.0 111.088 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p 47.39 64.65 1.51 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.215 2.206 . . . . 0.0 109.776 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 p -156.23 159.36 38.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 120.534 0.207 . . . . 0.0 110.495 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.31 39.16 27.85 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.83 1.681 . . . . 0.0 114.694 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -48.49 -40.4 26.42 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.649 1.224 . . . . 0.0 113.024 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 HH21 ' CE1' ' A' ' 61' ' ' HIS . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.443 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -70.74 -69.37 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.88 28.14 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.372 1.939 . . . . 0.0 111.781 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.49 -176.66 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.327 2.684 . . . . 0.0 111.482 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -55.75 171.96 0.2 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.765 1.626 . . . . 0.0 111.451 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.3 p -62.69 151.94 36.86 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.146 -0.971 . . . . 0.0 109.78 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 117.222 -1.877 . . . . 0.0 109.33 -179.431 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.36 168.07 20.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.814 0.846 . . . . 0.0 111.491 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -166.1 174.8 8.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 130.439 3.496 . . . . 0.0 105.159 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 50.65 0.03 OUTLIER Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 113.747 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.68 167.19 21.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.209 1.504 . . . . 0.0 108.532 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.8 m -130.35 91.72 3.15 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.783 1.233 . . . . 0.0 107.692 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 41.05 68.14 0.67 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 126.375 1.94 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -49.61 -46.94 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.538 1.535 . . . . 0.0 111.474 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.416 ' CE1' HD11 ' A' ' 31' ' ' LEU . 74.2 m-70 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 20' ' ' HIS . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 12.6 t -67.12 -31.6 72.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.25 -116.56 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.84 173.34 14.6 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.084 2.523 . . . . 0.0 110.287 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -164.95 149.82 9.34 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.701 0.8 . . . . 0.0 109.589 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.3 m -167.3 -175.61 2.98 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 130.279 3.431 . . . . 0.0 106.655 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -148.52 82.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.71 -47.83 83.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.783 0.833 . . . . 0.0 111.134 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.54 179.69 53.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -131.52 141.16 49.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.1 m -151.6 128.33 10.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.036 2.134 . . . . 0.0 106.513 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.94 103.71 1.26 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -45.63 -43.0 12.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 110.499 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.474 HD21 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 14' ' ' HIS . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' H ' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' NE2' ' H ' ' A' ' 47' ' ' GLN 0.256 0.4 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.407 ' CD2' ' HA ' ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 HD11 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -15.55 59.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.3 -166.64 52.55 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.263 1.411 . . . . 0.0 110.598 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.08 15.74 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.851 3.034 . . . . 0.0 114.162 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.06 12.33 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.675 -1.89 . . . . 0.0 113.19 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -131.75 8.93 4.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.456 1.103 . . . . 0.0 111.004 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -179.659 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -130.88 87.86 2.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -142.88 -156.72 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.784 1.634 . . . . 0.0 109.561 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -160.72 20.93 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m -68.85 68.27 0.16 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.705 1.602 . . . . 0.0 113.051 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -91.8 107.64 19.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 26.97 71.83 0.03 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 129.0 3.191 . . . . 0.0 117.194 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -54.64 -32.85 59.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.057 0.943 . . . . 0.0 110.491 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.495 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 12.2 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -60.72 2.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.8 164.85 38.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.26 120.32 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.732 2.955 . . . . 0.0 111.276 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.57 172.41 4.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.5 p -142.38 169.96 16.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.253 -0.904 . . . . 0.0 110.292 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.843 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -137.6 177.77 7.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 111.355 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p 39.97 54.81 2.64 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.842 2.457 . . . . 0.0 111.388 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.2 -21.61 60.47 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.428 -1.207 . . . . 0.0 115.258 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t 176.01 -176.07 0.11 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 128.92 2.888 . . . . 0.0 106.053 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 p -134.27 -9.05 2.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.158 1.783 . . . . 0.0 111.957 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.65 95.11 0.43 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -51.54 -34.72 37.76 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.367 1.067 . . . . 0.0 111.159 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 29.5 m-70 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.493 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.493 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 3.2 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 7.3 t -78.2 -23.18 47.63 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.68 -171.66 38.12 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 119.535 1.061 . . . . 0.0 112.619 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.07 113.72 3.35 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.85 3.034 . . . . 0.0 112.709 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 m -110.6 140.51 44.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.309 1.444 . . . . 0.0 107.888 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -138.21 -170.1 2.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.513 1.525 . . . . 0.0 109.905 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.549 -1.695 . . . . 0.0 110.926 179.67 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -167.11 134.53 2.45 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.861 1.33 . . . . 0.0 108.409 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -166.42 152.12 8.46 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.081 0.952 . . . . 0.0 108.831 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.05 85.24 0.06 OUTLIER Glycine 0 C--O 1.238 0.359 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.37 99.87 3.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.9 m -72.52 25.98 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.759 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.51 107.36 3.13 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 105.47 -3.052 . . . . 0.0 105.47 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.2 -44.52 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.246 1.018 . . . . 0.0 112.87 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HE ' ' H ' ' A' ' 73' ' ' LEU . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' H ' ' HE ' ' A' ' 72' ' ' ARG . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p -65.99 -41.67 90.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.33 -179.53 31.26 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.745 0.688 . . . . 0.0 111.486 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.6 -5.67 8.08 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.707 3.605 . . . . 0.0 112.627 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -76.1 127.46 32.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.464 1.106 . . . . 0.0 110.762 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 p -168.08 124.81 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.48 13.74 6.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.738 1.615 . . . . 0.0 113.644 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -131.44 107.72 9.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.79 2.76 0.03 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.91 -1.495 . . . . 0.0 115.171 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 m -57.48 105.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.897 1.849 . . . . 0.0 110.909 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -172.36 158.37 4.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.451 1.5 . . . . 0.0 108.183 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.09 25.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 105.638 -2.985 . . . . 0.0 105.638 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.57 -36.84 43.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -75.29 -15.47 60.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.04 -163.12 38.37 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.89 0.768 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.78 84.52 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.436 2.758 . . . . 0.0 108.894 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -149.31 146.87 27.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.142 0.496 . . . . 0.0 110.946 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 p -138.82 -15.1 1.18 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.856 2.062 . . . . 0.0 109.776 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 -179.627 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.352 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 p -94.46 -11.65 29.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.113 0.957 . . . . 0.0 110.813 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -70.47 154.53 41.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.301 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 170.47 25.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.93 44.06 1.93 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 126.903 2.081 . . . . 0.0 107.711 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -61.87 -18.66 60.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.88 83.75 0.05 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.567 1.531 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 pm0 -85.64 -39.75 16.95 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.126 1.77 . . . . 0.0 109.101 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -68.2 -36.75 80.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.11 179.83 48.24 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.43 1.014 . . . . 0.0 111.203 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.58 -14.06 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.282 2.655 . . . . 0.0 113.85 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -137.5 153.68 50.0 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 p -141.39 -178.45 5.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.153 1.781 . . . . 0.0 110.801 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 125.962 1.744 . . . . 0.0 109.763 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG21 ' HD3' ' A' ' 41' ' ' ARG . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HD3' HG21 ' A' ' 28' ' ' VAL . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 53' ' ' VAL . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 9' ' ' VAL . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 13' ' ' LEU . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 ' HD3' ' A' ' 41' ' ' ARG . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD3' HG21 ' A' ' 28' ' ' VAL . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.498 ' HA ' HD21 ' A' ' 73' ' ' LEU . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.41 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 64' ' ' ILE . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' CD ' ' A' ' 41' ' ' ARG . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 28' ' ' VAL . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.59 ' HA ' HD11 ' A' ' 73' ' ' LEU . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 64' ' ' ILE . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 84' ' ' LEU . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' HD21 ' A' ' 13' ' ' LEU . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 47' ' ' GLN . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.411 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 13' ' ' LEU . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 107' ' ' VAL . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 101' ' ' VAL . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 72' ' ' ARG . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 31' ' ' LEU . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 107' ' ' VAL . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 31' ' ' LEU . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HB3' HG11 ' A' ' 107' ' ' VAL . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.659 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' HG21 ' A' ' 101' ' ' VAL . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.659 HG22 ' CG ' ' A' ' 55' ' ' TRP . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 31' ' ' LEU . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 HH11 ' A' ' 60' ' ' ARG . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.476 HH11 HD23 ' A' ' 58' ' ' LEU . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 39' ' ' LEU . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.45 ' CE1' HD13 ' A' ' 31' ' ' LEU . 50.8 m80 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG21 ' HD3' ' A' ' 41' ' ' ARG . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' HG21 ' A' ' 28' ' ' VAL . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.543 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' ' 101' ' ' VAL . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 77' ' ' GLY . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 70' ' ' LEU . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 55' ' ' TRP . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 20.3 p . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.441 0.162 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.626 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 32' ' ' LEU . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 72' ' ' ARG . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.41 ' HB2' HD23 ' A' ' 83' ' ' LEU . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 53' ' ' VAL . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.132 0.491 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.427 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 13' ' ' LEU . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 32' ' ' LEU . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 28' ' ' VAL . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 53' ' ' VAL . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.439 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.457 HD12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HD21 ' A' ' 73' ' ' LEU . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 95' ' ' LEU . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HD3' HG21 ' A' ' 28' ' ' VAL . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 95' ' ' LEU . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 68' ' ' ASP . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.407 HH21 HD13 ' A' ' 67' ' ' LEU . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' HD23 ' A' ' 83' ' ' LEU . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 62' ' ' PHE . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 95' ' ' LEU . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.611 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' CE1' HD21 ' A' ' 13' ' ' LEU . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 77.1 m80 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 28' ' ' VAL . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 63' ' ' ILE . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' HD23 ' A' ' 83' ' ' LEU . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 80' ' ' SER . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 12.6 t . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.513 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' HD21 ' A' ' 13' ' ' LEU . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG13 HD21 ' A' ' 39' ' ' LEU . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' CD ' HG21 ' A' ' 28' ' ' VAL . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . 0.256 0.2 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.454 ' HB2' HD23 ' A' ' 83' ' ' LEU . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 53' ' ' VAL . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.518 0.675 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 pm0 -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 13' ' ' LEU . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HB2' HG12 ' A' ' 53' ' ' VAL . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HD3' HG21 ' A' ' 28' ' ' VAL . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.432 ' CB ' HG22 ' A' ' 101' ' ' VAL . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.439 ' HB2' HD23 ' A' ' 83' ' ' LEU . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 80' ' ' SER . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.499 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 2.8 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 55' ' ' TRP . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 9.9 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.463 0.217 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.649 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 13' ' ' LEU . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 107' ' ' VAL . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 39' ' ' LEU . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' H ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' HD12 ' A' ' 32' ' ' LEU . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 28' ' ' VAL . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.49 HD11 ' HE ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HE ' HD11 ' A' ' 67' ' ' LEU . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 81' ' ' ILE . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.226 -0.171 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CE1' HD21 ' A' ' 13' ' ' LEU . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.01 175.32 14.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.716 0.758 . . . . 0.0 109.173 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -155.49 178.95 9.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 129.51 3.124 . . . . 0.0 106.213 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.96 21.27 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.315 1.436 . . . . 0.0 109.944 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -146.91 121.93 10.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.3 t -149.02 176.77 10.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.755 1.622 . . . . 0.0 109.58 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.61 75.43 1.83 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.005 0.922 . . . . 0.0 112.292 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG21 ' HD3' ' A' ' 41' ' ' ARG . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HD3' HG21 ' A' ' 28' ' ' VAL . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 53' ' ' VAL . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -58.18 -43.02 87.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.82 175.51 29.84 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.15 -1.31 6.9 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.105 2.537 . . . . 0.0 113.73 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -59.51 -42.53 92.4 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.583 1.953 . . . . 0.0 113.221 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -154.92 162.92 40.95 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.525 1.53 . . . . 0.0 108.268 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.899 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -66.94 160.12 27.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 m -79.1 168.91 18.96 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.643 -0.661 . . . . 0.0 110.173 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.31 104.2 0.18 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -155.95 170.25 22.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.536 2.335 . . . . 0.0 107.836 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -138.01 112.66 8.88 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.219 1.007 . . . . 0.0 108.785 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.57 94.18 0.79 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -14.74 63.21 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 121.542 -0.975 . . . . 0.0 110.499 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 9' ' ' VAL . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 13' ' ' LEU . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 ' HD3' ' A' ' 41' ' ' ARG . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD3' HG21 ' A' ' 28' ' ' VAL . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.498 ' HA ' HD21 ' A' ' 73' ' ' LEU . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.41 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 64' ' ' ILE . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t -56.54 -48.18 77.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.82 151.77 5.93 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.06 62.19 7.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.918 3.079 . . . . 0.0 111.478 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 t -72.95 139.83 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.219 -0.926 . . . . 0.0 110.026 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.8 m -74.04 -22.64 59.48 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.944 0.497 . . . . 0.0 111.106 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -151.59 156.13 39.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -72.38 111.64 7.75 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.02 42.23 2.96 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 t -154.29 167.77 28.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.209 1.803 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -120.98 11.82 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.433 2.293 . . . . 0.0 109.188 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.87 103.85 2.9 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -57.58 -30.4 65.25 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.127 0.964 . . . . 0.0 112.013 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' CD ' ' A' ' 41' ' ' ARG . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 28' ' ' VAL . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.59 ' HA ' HD11 ' A' ' 73' ' ' LEU . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 64' ' ' ILE . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 84' ' ' LEU . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 t -58.0 -52.8 64.0 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.39 -149.67 49.91 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.23 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.2 134.69 29.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.989 2.459 . . . . 0.0 111.391 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 p -132.49 141.67 48.88 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.67 1.988 . . . . 0.0 107.359 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 m -83.51 -11.37 57.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.474 0.579 . . . . 0.0 111.648 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 C-N-CA 129.212 3.291 . . . . 0.0 105.381 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.742 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.6 80.64 1.74 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.776 0.83 . . . . 0.0 111.333 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 t -145.31 -177.38 5.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.567 1.547 . . . . 0.0 107.489 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.22 -144.49 8.71 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 120.996 -1.065 . . . . 0.0 111.833 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -70.29 88.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 108.607 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -142.02 154.2 44.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.984 0.914 . . . . 0.0 109.115 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.68 78.68 1.89 Allowed Glycine 0 C--N 1.331 0.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.75 -33.28 34.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.51 1.524 . . . . 0.0 111.308 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' HD21 ' A' ' 13' ' ' LEU . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 47' ' ' GLN . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.411 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -67.06 -49.23 65.8 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 149.82 -167.85 29.92 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.7 13.66 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.224 3.283 . . . . 0.0 114.228 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 p -58.03 168.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.942 1.697 . . . . 0.0 113.456 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -71.0 162.17 29.88 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.734 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -173.76 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -143.82 153.83 42.77 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.74 154.0 25.65 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -80.54 -172.98 3.86 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.586 2.354 . . . . 0.0 112.541 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -132.11 135.22 46.26 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.048 1.739 . . . . 0.0 106.487 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.83 81.22 1.24 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 106.051 -2.819 . . . . 0.0 106.051 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -48.69 -36.71 16.76 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.73 2.012 . . . . 0.0 113.273 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 13' ' ' LEU . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 107' ' ' VAL . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 101' ' ' VAL . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 72' ' ' ARG . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 31' ' ' LEU . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.9 p -72.11 -31.02 65.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.82 -174.98 13.71 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.311 1.91 . . . . 0.0 111.003 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.49 162.11 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.513 2.808 . . . . 0.0 113.749 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -158.92 155.18 27.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.484 1.114 . . . . 0.0 109.758 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -82.74 -67.13 0.81 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 110.429 179.398 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -140.25 166.14 25.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.48 0.712 . . . . 0.0 111.284 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -108.46 -151.6 0.47 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.795 2.038 . . . . 0.0 110.235 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.96 -21.89 37.25 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 125.005 1.288 . . . . 0.0 113.827 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -100.14 117.89 35.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.869 1.268 . . . . 0.0 113.031 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -133.55 179.96 5.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.019 1.728 . . . . 0.0 107.591 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.09 12.33 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.954 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -52.04 -33.94 40.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.802 1.241 . . . . 0.0 113.347 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 107' ' ' VAL . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 31' ' ' LEU . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p -56.62 -54.96 39.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.72 150.48 7.37 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.88 -14.14 21.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 114.686 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.9 m -61.95 -23.12 66.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -135.42 18.15 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.52 1.128 . . . . 0.0 110.899 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -79.51 15.18 1.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -55.84 162.95 1.59 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.49 76.82 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -98.82 103.1 15.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -149.85 163.28 38.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.02 113.45 3.98 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 104.561 -3.416 . . . . 0.0 104.561 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -46.83 -37.57 8.92 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.62 2.368 . . . . 0.0 112.465 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HB3' HG11 ' A' ' 107' ' ' VAL . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.659 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' HG21 ' A' ' 101' ' ' VAL . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG22 ' CG ' ' A' ' 55' ' ' TRP . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 31' ' ' LEU . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.72 -16.63 29.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.89 115.38 3.16 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.681 -1.066 . . . . 0.0 112.623 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.57 -3.56 11.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.04 3.827 . . . . 0.0 113.544 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.8 t -61.83 -28.08 69.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.46 1.027 . . . . 0.0 109.617 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -55.04 102.72 0.07 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.718 2.407 . . . . 0.0 109.859 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 C-N-CA 125.29 1.424 . . . . 0.0 110.701 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -166.68 164.98 16.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.366 1.867 . . . . 0.0 106.208 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -75.45 -169.58 1.04 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.598 0.759 . . . . 0.0 109.548 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.98 -146.88 18.05 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 120.828 -1.17 . . . . 0.0 114.765 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 t -149.8 85.95 1.44 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.752 1.221 . . . . 0.0 109.074 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -62.16 -27.78 69.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.493 0.717 . . . . 0.0 112.905 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.22 142.91 6.21 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 106.604 -2.599 . . . . 0.0 106.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 3.3 mt-10 -64.67 -48.11 75.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 HH11 ' A' ' 60' ' ' ARG . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.476 HH11 HD23 ' A' ' 58' ' ' LEU . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 39' ' ' LEU . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t -101.0 -34.73 9.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.38 -119.99 5.7 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 118.081 1.992 . . . . 0.0 118.081 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.26 38.43 0.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 1 C-N-CA 126.553 4.835 . . . . 0.0 116.298 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -57.34 -36.28 70.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.542 1.137 . . . . 0.0 111.598 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -132.51 -175.8 3.88 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.293 1.437 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.811 0 CA-C-O 117.013 -1.993 . . . . 0.0 109.701 -179.562 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 p -61.04 4.27 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.981 2.912 . . . . 0.0 115.883 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.5 154.49 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.528 1.058 . . . . 0.0 111.861 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.95 -173.47 44.97 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -145.6 -170.32 3.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 109.522 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -135.27 12.59 3.54 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.372 -0.83 . . . . 0.0 112.153 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.28 82.15 0.16 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -52.03 -50.63 61.04 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.756 1.223 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.45 ' CE1' HD13 ' A' ' 31' ' ' LEU . 50.8 m80 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG21 ' HD3' ' A' ' 41' ' ' ARG . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' HG21 ' A' ' 28' ' ' VAL . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.543 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' ' 101' ' ' VAL . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 77' ' ' GLY . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 70' ' ' LEU . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 55' ' ' TRP . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 20.3 p -76.13 -25.98 55.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.19 -168.11 22.59 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.107 0.384 . . . . 0.0 112.174 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.4 15.89 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.742 3.628 . . . . 0.0 114.222 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.4 t -127.72 81.04 2.0 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.12 1.368 . . . . 0.0 108.314 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 t -91.76 116.33 28.81 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.865 -179.795 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 m -169.98 162.14 9.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.612 1.965 . . . . 0.0 107.764 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.6 m -104.67 -90.59 0.39 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.133 0.973 . . . . 0.0 108.993 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.01 20.37 0.21 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.552 1.072 . . . . 0.0 112.85 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -51.28 104.42 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.547 1.539 . . . . 0.0 113.49 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t -157.94 110.72 2.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.229 1.012 . . . . 0.0 109.615 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.78 65.38 0.76 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.14 1.353 . . . . 0.0 112.579 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.98 -33.61 72.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.755 0.778 . . . . 0.0 110.992 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.626 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 32' ' ' LEU . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 72' ' ' ARG . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.41 ' HB2' HD23 ' A' ' 83' ' ' LEU . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 53' ' ' VAL . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p -79.25 -25.25 42.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.81 169.32 12.74 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.612 1.577 . . . . 0.0 109.967 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.43 10.45 3.26 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.595 2.863 . . . . 0.0 113.559 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 -20.23 63.16 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.817 -1.177 . . . . 0.0 111.942 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -140.97 73.49 1.42 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.898 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -132.43 64.62 1.6 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 117.616 0.708 . . . . 0.0 109.93 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t -75.53 96.74 3.56 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 102.597 -3.112 . . . . 0.0 102.597 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.57 72.03 0.36 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -140.19 154.16 46.84 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.899 1.68 . . . . 0.0 107.352 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 p -120.35 -173.74 2.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.85 61.11 4.85 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.885 1.707 . . . . 0.0 111.8 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.62 -31.47 66.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.448 0.699 . . . . 0.0 111.727 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.427 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 13' ' ' LEU . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 32' ' ' LEU . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 28' ' ' VAL . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 53' ' ' VAL . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.439 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t -74.58 -30.62 61.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.74 147.91 35.98 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.48 87.14 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.577 3.518 . . . . 0.0 110.591 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -51.69 149.58 4.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.662 1.185 . . . . 0.0 107.821 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.1 m 79.43 11.49 1.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.0 110.65 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 C-N-CA 129.239 3.304 . . . . 0.0 106.946 178.899 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -101.32 117.4 34.9 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.949 2.1 . . . . 0.0 106.404 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -147.83 143.63 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.571 1.148 . . . . 0.0 109.275 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.32 106.42 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -148.24 20.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.267 1.034 . . . . 0.0 111.924 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -71.54 -174.67 1.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.718 0.69 . . . . 0.0 109.938 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 96.02 0.99 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 103.537 -3.825 . . . . 0.0 103.537 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -31.68 51.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.589 0.695 . . . . 0.0 112.638 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.457 HD12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HD21 ' A' ' 73' ' ' LEU . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 95' ' ' LEU . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p -75.85 -38.02 58.42 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.12 -179.38 31.12 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.588 1.09 . . . . 0.0 112.316 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -80.49 44.51 1.75 Allowed 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.064 4.509 . . . . 0.0 112.795 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -97.71 153.38 18.28 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.827 -1.17 . . . . 0.0 113.078 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.2 m -150.87 152.06 33.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.013 2.125 . . . . 0.0 106.971 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.104 -1.387 . . . . 0.0 110.634 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.187 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -116.72 -83.65 0.63 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -70.86 -5.48 30.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.932 1.242 . . . . 0.0 112.289 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.34 3.01 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.932 1.729 . . . . 0.0 111.088 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p 47.39 64.65 1.51 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.215 2.206 . . . . 0.0 109.776 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 p -156.23 159.36 38.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 120.534 0.207 . . . . 0.0 110.495 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.31 39.16 27.85 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.83 1.681 . . . . 0.0 114.694 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -48.49 -40.4 26.42 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.649 1.224 . . . . 0.0 113.024 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HD3' HG21 ' A' ' 28' ' ' VAL . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 95' ' ' LEU . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 68' ' ' ASP . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.407 HH21 HD13 ' A' ' 67' ' ' LEU . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' HD23 ' A' ' 83' ' ' LEU . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 62' ' ' PHE . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 95' ' ' LEU . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -70.74 -69.37 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.88 28.14 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.372 1.939 . . . . 0.0 111.781 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.49 -176.66 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.327 2.684 . . . . 0.0 111.482 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -55.75 171.96 0.2 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.765 1.626 . . . . 0.0 111.451 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.3 p -62.69 151.94 36.86 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.146 -0.971 . . . . 0.0 109.78 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 117.222 -1.877 . . . . 0.0 109.33 -179.431 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.36 168.07 20.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.814 0.846 . . . . 0.0 111.491 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -166.1 174.8 8.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 130.439 3.496 . . . . 0.0 105.159 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 50.65 0.03 OUTLIER Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 113.747 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.68 167.19 21.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.209 1.504 . . . . 0.0 108.532 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.8 m -130.35 91.72 3.15 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.783 1.233 . . . . 0.0 107.692 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 41.05 68.14 0.67 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 126.375 1.94 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -49.61 -46.94 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.538 1.535 . . . . 0.0 111.474 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.611 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' CE1' HD21 ' A' ' 13' ' ' LEU . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 77.1 m80 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 28' ' ' VAL . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 63' ' ' ILE . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' HD23 ' A' ' 83' ' ' LEU . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 80' ' ' SER . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 12.6 t -67.12 -31.6 72.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.25 -116.56 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.84 173.34 14.6 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.084 2.523 . . . . 0.0 110.287 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -164.95 149.82 9.34 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.701 0.8 . . . . 0.0 109.589 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.3 m -167.3 -175.61 2.98 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 130.279 3.431 . . . . 0.0 106.655 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -148.52 82.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.71 -47.83 83.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.783 0.833 . . . . 0.0 111.134 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.54 179.69 53.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -131.52 141.16 49.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.1 m -151.6 128.33 10.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.036 2.134 . . . . 0.0 106.513 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.94 103.71 1.26 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -45.63 -43.0 12.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 110.499 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.513 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' HD21 ' A' ' 13' ' ' LEU . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG13 HD21 ' A' ' 39' ' ' LEU . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' CD ' HG21 ' A' ' 28' ' ' VAL . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . 0.256 0.2 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.454 ' HB2' HD23 ' A' ' 83' ' ' LEU . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 53' ' ' VAL . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -15.55 59.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.3 -166.64 52.55 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.263 1.411 . . . . 0.0 110.598 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.08 15.74 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.851 3.034 . . . . 0.0 114.162 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.06 12.33 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.675 -1.89 . . . . 0.0 113.19 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -131.75 8.93 4.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.456 1.103 . . . . 0.0 111.004 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -179.659 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -130.88 87.86 2.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -142.88 -156.72 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.784 1.634 . . . . 0.0 109.561 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -160.72 20.93 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m -68.85 68.27 0.16 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.705 1.602 . . . . 0.0 113.051 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -91.8 107.64 19.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 26.97 71.83 0.03 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 129.0 3.191 . . . . 0.0 117.194 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -54.64 -32.85 59.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.057 0.943 . . . . 0.0 110.491 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 pm0 -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 13' ' ' LEU . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HB2' HG12 ' A' ' 53' ' ' VAL . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HD3' HG21 ' A' ' 28' ' ' VAL . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.432 ' CB ' HG22 ' A' ' 101' ' ' VAL . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.439 ' HB2' HD23 ' A' ' 83' ' ' LEU . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 80' ' ' SER . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.499 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 2.8 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 55' ' ' TRP . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -60.72 2.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.8 164.85 38.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.26 120.32 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.732 2.955 . . . . 0.0 111.276 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.57 172.41 4.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.5 p -142.38 169.96 16.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.253 -0.904 . . . . 0.0 110.292 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.843 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -137.6 177.77 7.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 111.355 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p 39.97 54.81 2.64 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.842 2.457 . . . . 0.0 111.388 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.2 -21.61 60.47 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.428 -1.207 . . . . 0.0 115.258 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t 176.01 -176.07 0.11 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 128.92 2.888 . . . . 0.0 106.053 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 p -134.27 -9.05 2.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.158 1.783 . . . . 0.0 111.957 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.65 95.11 0.43 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -51.54 -34.72 37.76 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.367 1.067 . . . . 0.0 111.159 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 9.9 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 t -78.2 -23.18 47.63 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.68 -171.66 38.12 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 119.535 1.061 . . . . 0.0 112.619 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.07 113.72 3.35 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.85 3.034 . . . . 0.0 112.709 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 m -110.6 140.51 44.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.309 1.444 . . . . 0.0 107.888 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -138.21 -170.1 2.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.513 1.525 . . . . 0.0 109.905 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.549 -1.695 . . . . 0.0 110.926 179.67 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -167.11 134.53 2.45 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.861 1.33 . . . . 0.0 108.409 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -166.42 152.12 8.46 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.081 0.952 . . . . 0.0 108.831 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.05 85.24 0.06 OUTLIER Glycine 0 C--O 1.238 0.359 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.37 99.87 3.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.9 m -72.52 25.98 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.759 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.51 107.36 3.13 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 105.47 -3.052 . . . . 0.0 105.47 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.2 -44.52 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.246 1.018 . . . . 0.0 112.87 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.649 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 13' ' ' LEU . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 107' ' ' VAL . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 39' ' ' LEU . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p -65.99 -41.67 90.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.33 -179.53 31.26 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.745 0.688 . . . . 0.0 111.486 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.6 -5.67 8.08 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.707 3.605 . . . . 0.0 112.627 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -76.1 127.46 32.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.464 1.106 . . . . 0.0 110.762 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 p -168.08 124.81 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.48 13.74 6.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.738 1.615 . . . . 0.0 113.644 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -131.44 107.72 9.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.79 2.76 0.03 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.91 -1.495 . . . . 0.0 115.171 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 m -57.48 105.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.897 1.849 . . . . 0.0 110.909 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -172.36 158.37 4.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.451 1.5 . . . . 0.0 108.183 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.09 25.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 105.638 -2.985 . . . . 0.0 105.638 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.57 -36.84 43.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' H ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' HD12 ' A' ' 32' ' ' LEU . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 28' ' ' VAL . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.49 HD11 ' HE ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HE ' HD11 ' A' ' 67' ' ' LEU . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 81' ' ' ILE . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -75.29 -15.47 60.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.04 -163.12 38.37 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.89 0.768 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.78 84.52 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.436 2.758 . . . . 0.0 108.894 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -149.31 146.87 27.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.142 0.496 . . . . 0.0 110.946 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 p -138.82 -15.1 1.18 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.856 2.062 . . . . 0.0 109.776 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 -179.627 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.352 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 p -94.46 -11.65 29.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.113 0.957 . . . . 0.0 110.813 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -70.47 154.53 41.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.301 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 170.47 25.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.93 44.06 1.93 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 126.903 2.081 . . . . 0.0 107.711 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -61.87 -18.66 60.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.88 83.75 0.05 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.567 1.531 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 1.6 pm0 -85.64 -39.75 16.95 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.126 1.77 . . . . 0.0 109.101 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CE1' HD21 ' A' ' 13' ' ' LEU . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -68.2 -36.75 80.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.11 179.83 48.24 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.43 1.014 . . . . 0.0 111.203 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.58 -14.06 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.282 2.655 . . . . 0.0 113.85 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -137.5 153.68 50.0 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 p -141.39 -178.45 5.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.153 1.781 . . . . 0.0 110.801 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 125.962 1.744 . . . . 0.0 109.763 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 33.2 m-70 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG21 ' HD3' ' A' ' 41' ' ' ARG . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 20' ' ' HIS . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HD3' HG21 ' A' ' 28' ' ' VAL . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 53' ' ' VAL . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 2.3 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 9' ' ' VAL . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 13' ' ' LEU . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 ' HD3' ' A' ' 41' ' ' ARG . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD3' HG21 ' A' ' 28' ' ' VAL . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.498 ' HA ' HD21 ' A' ' 73' ' ' LEU . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.41 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 64' ' ' ILE . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 43.5 m-70 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' CD ' ' A' ' 41' ' ' ARG . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 28' ' ' VAL . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.59 ' HA ' HD11 ' A' ' 73' ' ' LEU . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 64' ' ' ILE . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 84' ' ' LEU . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 10.4 t . . . . . 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' HD21 ' A' ' 13' ' ' LEU . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 47' ' ' GLN . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.411 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 13' ' ' LEU . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 47.0 m-70 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 107' ' ' VAL . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 101' ' ' VAL . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 72' ' ' ARG . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 31' ' ' LEU . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.492 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 29.9 p . . . . . 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 107' ' ' VAL . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 31' ' ' LEU . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HB3' HG11 ' A' ' 107' ' ' VAL . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.659 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' HG21 ' A' ' 101' ' ' VAL . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.659 HG22 ' CG ' ' A' ' 55' ' ' TRP . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 31' ' ' LEU . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 HH11 ' A' ' 60' ' ' ARG . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.476 HH11 HD23 ' A' ' 58' ' ' LEU . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.416 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 13.0 m-70 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 39' ' ' LEU . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 44.0 m-70 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG21 ' HD3' ' A' ' 41' ' ' ARG . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' HG21 ' A' ' 28' ' ' VAL . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.543 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' ' 101' ' ' VAL . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 77' ' ' GLY . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 70' ' ' LEU . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 55' ' ' TRP . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 20.3 p . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.441 0.162 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.626 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 32' ' ' LEU . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 72' ' ' ARG . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.41 ' HB2' HD23 ' A' ' 83' ' ' LEU . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 53' ' ' VAL . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.132 0.491 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.427 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 13' ' ' LEU . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 32' ' ' LEU . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 28' ' ' VAL . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 53' ' ' VAL . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.439 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.457 HD12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HD21 ' A' ' 73' ' ' LEU . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 95' ' ' LEU . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HD3' HG21 ' A' ' 28' ' ' VAL . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 95' ' ' LEU . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 68' ' ' ASP . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.407 HH21 HD13 ' A' ' 67' ' ' LEU . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' HD23 ' A' ' 83' ' ' LEU . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 62' ' ' PHE . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 95' ' ' LEU . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.611 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' CE1' HD21 ' A' ' 13' ' ' LEU . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.557 ' CE1' HD13 ' A' ' 31' ' ' LEU . 74.2 m-70 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD13 ' CE1' ' A' ' 20' ' ' HIS . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 28' ' ' VAL . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 63' ' ' ILE . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' HD23 ' A' ' 83' ' ' LEU . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 80' ' ' SER . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 12.6 t . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.513 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' HD21 ' A' ' 13' ' ' LEU . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG13 HD21 ' A' ' 39' ' ' LEU . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' CD ' HG21 ' A' ' 28' ' ' VAL . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.53 ' NE2' ' H ' ' A' ' 47' ' ' GLN 0.256 0.4 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.454 ' HB2' HD23 ' A' ' 83' ' ' LEU . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 53' ' ' VAL . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.518 0.675 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 13' ' ' LEU . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.499 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HB2' HG12 ' A' ' 53' ' ' VAL . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HD3' HG21 ' A' ' 28' ' ' VAL . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.432 ' CB ' HG22 ' A' ' 101' ' ' VAL . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.439 ' HB2' HD23 ' A' ' 83' ' ' LEU . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 80' ' ' SER . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.499 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 12.2 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 55' ' ' TRP . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' HD13 ' A' ' 31' ' ' LEU . 29.5 m-70 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 20' ' ' HIS . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 3.2 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 7.3 t . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.463 0.217 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 HG13 HE21 ' A' ' 10' ' ' GLN . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.462 HE21 HG13 ' A' ' 9' ' ' VAL . 64.5 mm-40 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.649 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 13' ' ' LEU . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 107' ' ' VAL . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 39' ' ' LEU . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' HD12 ' A' ' 32' ' ' LEU . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 28' ' ' VAL . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.49 HD11 ' HE ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HE ' HD11 ' A' ' 67' ' ' LEU . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 81' ' ' ILE . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.226 -0.171 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CE1' HD21 ' A' ' 13' ' ' LEU . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.01 175.32 14.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.716 0.758 . . . . 0.0 109.173 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -155.49 178.95 9.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 129.51 3.124 . . . . 0.0 106.213 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.96 21.27 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.315 1.436 . . . . 0.0 109.944 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -146.91 121.93 10.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.3 t -149.02 176.77 10.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.755 1.622 . . . . 0.0 109.58 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.61 75.43 1.83 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.005 0.922 . . . . 0.0 112.292 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.2 -31.46 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.269 0.486 . . . . 0.0 111.507 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -81.77 -3.58 54.2 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.254 -0.904 . . . . 0.0 113.023 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.6 mmpt? -60.11 140.14 90.95 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 120.081 1.309 . . . . 0.0 109.523 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.07 144.76 99.45 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.512 2.141 . . . . 0.0 110.795 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.08 -36.56 63.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.143 0.577 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -59.46 -17.75 33.91 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.51 -3.81 16.71 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.905 1.684 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -60.56 132.76 54.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.7 62.79 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.926 0.89 . . . . 0.0 111.623 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -90.0 3.43 53.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 113.487 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -99.0 83.51 2.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 120.056 1.298 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 33.2 m-70 -73.28 -9.09 58.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.4 -164.85 29.65 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.696 1.135 . . . . 0.0 112.193 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.92 26.89 0.09 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.93 1.292 . . . . 0.0 113.991 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 pt -55.22 149.94 23.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.019 1.328 . . . . 0.0 113.028 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.61 163.09 32.28 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.65 2.233 . . . . 0.0 111.12 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -24.74 60.54 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.02 70.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.801 0.728 . . . . 0.0 109.463 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.34 -43.07 64.62 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG21 ' HD3' ' A' ' 41' ' ' ARG . 92.0 t -55.93 -47.11 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 111.078 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -24.05 53.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.17 -0.06 56.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.432 0.693 . . . . 0.0 111.832 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 20' ' ' HIS . 35.7 mt -95.5 -48.0 6.02 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.106 -0.996 . . . . 0.0 110.522 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.18 115.48 21.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.584 0.754 . . . . 0.0 109.462 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.25 -33.66 2.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -125.82 166.72 16.33 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -65.85 126.24 27.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.943 0.897 . . . . 0.0 108.806 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.83 -13.13 45.99 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.925 -0.93 . . . . 0.0 112.098 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.17 133.27 46.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.6 p90 -143.01 157.36 44.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.27 165.96 35.05 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.794 2.038 . . . . 0.0 109.504 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.98 131.76 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HD3' HG21 ' A' ' 28' ' ' VAL . 43.9 ptt85 -125.59 158.9 33.46 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.24 145.67 26.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.9 m -68.44 152.61 45.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.449 1.119 . . . . 0.0 110.931 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.85 121.14 17.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -76.97 1.17 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.686 1.136 . . . . 0.0 111.642 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -54.23 131.93 42.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.577 2.351 . . . . 0.0 108.951 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -83.41 76.6 9.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.052 0.541 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.34 135.42 33.74 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.39 1.076 . . . . 0.0 109.31 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -85.71 152.6 22.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.12 0.962 . . . . 0.0 110.582 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.57 120.85 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.807 1.243 . . . . 0.0 109.06 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -85.44 130.35 34.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 t -121.71 124.47 44.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -134.18 151.7 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.32 142.26 33.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.802 0.841 . . . . 0.0 109.822 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -164.04 142.5 7.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.362 1.465 . . . . 0.0 107.381 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 56.07 8.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.662 1.585 . . . . 0.0 114.844 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.22 19.62 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.928 -1.732 . . . . 0.0 112.574 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.54 115.07 5.24 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.92 112.18 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.456 2.104 . . . . 0.0 107.767 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.2 162.19 24.81 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.691 1.197 . . . . 0.0 109.256 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -133.16 122.01 23.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -121.85 103.55 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.51 1.124 . . . . 0.0 108.481 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.91 119.33 12.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.12 135.06 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -100.88 146.24 27.59 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -136.69 129.26 30.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.921 2.088 . . . . 0.0 107.027 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -153.89 -61.05 0.13 Allowed 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 117.962 0.347 . . . . 0.0 110.981 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 85.6 m-20 -78.23 30.65 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.295 1.838 . . . . 0.0 112.025 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.4 t30 66.71 9.49 6.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.62 1.568 . . . . 0.0 110.866 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -129.61 153.21 48.31 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 129.975 3.31 . . . . 0.0 107.753 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 61.4 m-85 -105.31 141.84 36.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -155.5 -177.59 6.66 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.369 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.71 -33.13 0.47 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -156.93 -31.2 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.93 1.241 . . . . 0.0 112.364 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.92 -136.52 6.13 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 125.852 1.692 . . . . 0.0 108.889 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -70.6 167.52 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.667 0.746 . . . . 0.0 111.241 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.88 177.18 17.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.204 1.859 . . . . 0.0 108.722 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -142.6 164.92 29.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 124.082 0.953 . . . . 0.0 109.478 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.2 -7.16 16.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.903 1.735 . . . . 0.0 113.398 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -152.79 157.72 41.2 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.763 1.619 . . . . 0.0 111.296 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 mm -57.83 -51.27 82.98 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.809 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.18 -38.89 52.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 121.45 1.554 . . . . 0.0 111.978 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.0 -42.56 76.6 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.374 0.67 . . . . 0.0 110.376 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.77 -52.81 15.73 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.692 0.797 . . . . 0.0 110.41 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.5 -46.97 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.748 0.704 . . . . 0.0 109.753 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -58.21 -43.52 87.69 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.589 1.156 . . . . 0.0 108.748 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.8 -45.42 94.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.095 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -36.77 85.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.635 1.561 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.86 -27.45 67.54 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 t -82.96 -56.13 3.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.725 2.41 . . . . 0.0 111.973 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.4 p -88.21 -11.43 46.72 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.53 31.4 20.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.054 1.742 . . . . 0.0 113.981 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.14 145.96 91.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.76 149.03 53.67 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.719 1.613 . . . . 0.0 109.764 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.88 -42.49 99.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.725 1.61 . . . . 0.0 112.893 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.06 136.24 11.93 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.087 1.355 . . . . 0.0 108.345 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -53.55 -40.36 65.48 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.784 0.833 . . . . 0.0 110.991 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -60.96 -10.53 5.92 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.53 -39.44 0.81 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.998 1.272 . . . . 0.0 111.301 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.13 19.86 79.54 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.273 -0.892 . . . . 0.0 113.326 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 53' ' ' VAL . 59.4 t -72.53 146.03 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.366 1.083 . . . . 0.0 109.116 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.4 156.85 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.84 128.11 42.44 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -112.33 -40.52 4.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.282 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -159.61 146.64 16.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.146 0.885 . . . . 0.0 109.412 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.47 162.23 25.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 0.0 109.372 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.93 124.86 28.79 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.09 159.23 33.87 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.239 1.959 . . . . 0.0 111.482 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 2.3 p -58.18 -43.02 87.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.521 1.128 . . . . 0.0 110.761 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.82 175.51 29.84 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.15 -1.31 6.9 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.105 2.537 . . . . 0.0 113.73 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -59.51 -42.53 92.4 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.583 1.953 . . . . 0.0 113.221 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -154.92 162.92 40.95 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.525 1.53 . . . . 0.0 108.268 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.899 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -66.94 160.12 27.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 m -79.1 168.91 18.96 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.643 -0.661 . . . . 0.0 110.173 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.31 104.2 0.18 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -155.95 170.25 22.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.536 2.335 . . . . 0.0 107.836 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -138.01 112.66 8.88 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.219 1.007 . . . . 0.0 108.785 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.57 94.18 0.79 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -14.74 63.21 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 121.542 -0.975 . . . . 0.0 110.499 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 9' ' ' VAL . 21.7 t -48.62 -40.74 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.185 2.194 . . . . 0.0 112.38 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.32 -23.06 57.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -67.22 156.43 88.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.23 164.25 26.17 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.214 1.276 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.1 tt -59.79 -36.71 77.28 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.738 -0.601 . . . . 0.0 109.533 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 p-80 -67.06 -9.2 36.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.8 -11.61 18.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.538 1.063 . . . . 0.0 111.247 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -63.09 137.1 58.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.891 0.876 . . . . 0.0 111.806 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.15 -39.92 76.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.242 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -73.84 -10.16 59.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.948 1.699 . . . . 0.0 114.43 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 13' ' ' LEU . 68.4 t80 -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -79.89 -58.91 2.94 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.71 84.92 0.77 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 112.695 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.74 33.02 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.426 2.691 . . . . 0.0 114.212 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.21 148.87 98.27 Favored Pre-proline 0 C--O 1.239 0.513 0 O-C-N 121.165 -0.959 . . . . 0.0 111.672 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.66 164.09 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.451 2.101 . . . . 0.0 110.464 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -58.88 -27.13 64.91 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.2 67.38 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.59 1.156 . . . . 0.0 111.049 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.37 -49.55 5.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 ' HD3' ' A' ' 41' ' ' ARG . 93.3 t -46.71 -58.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 125.031 1.332 . . . . 0.0 111.318 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.45 -18.44 4.25 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -99.39 -22.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.405 1.002 . . . . 0.0 111.742 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.66 -43.44 69.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.647 1.112 . . . . 0.0 110.368 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.93 135.27 35.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 t -131.12 -31.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.389 0.675 . . . . 0.0 111.236 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -116.35 131.99 56.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.385 0.993 . . . . 0.0 109.855 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.9 m -53.24 116.69 2.54 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.719 0.808 . . . . 0.0 111.16 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.47 -12.07 13.97 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.808 2.147 . . . . 0.0 109.562 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.52 142.1 57.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -146.66 162.98 37.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.269 0.94 . . . . 0.0 112.538 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.08 172.32 18.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.826 2.05 . . . . 0.0 109.318 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.91 133.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD3' HG21 ' A' ' 28' ' ' VAL . 44.5 ptt85 -131.45 139.33 49.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.951 0.9 . . . . 0.0 109.055 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -79.2 147.61 32.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 t -63.8 158.7 21.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.949 0.899 . . . . 0.0 109.643 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -75.44 84.72 2.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.502 -0.749 . . . . 0.0 109.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.16 9.6 44.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 117.849 -1.528 . . . . 0.0 116.17 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -134.34 144.97 48.58 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.702 2.251 . . . . 0.0 108.179 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.97 37.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.271 1.828 . . . . 0.0 110.731 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.03 135.04 46.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.225 3.01 . . . . 0.0 108.081 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -104.38 136.01 44.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 123.37 0.668 . . . . 0.0 109.282 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.9 t -121.08 123.07 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.59 1.156 . . . . 0.0 108.901 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.49 139.34 30.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.31 127.53 33.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' CG2' ' CG1' ' A' ' 101' ' ' VAL . 1.6 m -134.1 164.66 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.45 138.65 46.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -158.1 136.67 11.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 51.77 34.3 12.85 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.228 1.411 . . . . 0.0 111.992 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.81 40.55 97.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.312 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.54 120.92 6.23 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.555 1.177 . . . . 0.0 109.512 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.97 98.29 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.786 2.324 . . . . 0.0 108.92 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -78.51 119.62 22.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.814 2.046 . . . . 0.0 109.954 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -93.89 129.78 40.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.734 1.214 . . . . 0.0 109.489 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -127.47 100.06 5.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.174 1.389 . . . . 0.0 109.176 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.98 97.02 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.293 2.237 . . . . 0.0 106.203 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.498 ' HA ' HD21 ' A' ' 73' ' ' LEU . 20.9 mt -56.38 108.68 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.397 1.479 . . . . 0.0 108.955 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -73.04 155.01 40.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -126.91 133.55 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.008 0.923 . . . . 0.0 108.798 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' CD2' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -157.84 135.7 10.68 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.61 25.22 6.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.355 1.462 . . . . 0.0 112.825 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 75.05 14.17 3.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.833 2.053 . . . . 0.0 110.901 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.36 165.29 12.59 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.328 1.851 . . . . 0.0 108.048 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -130.09 136.85 49.78 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.877 1.271 . . . . 0.0 108.896 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.41 HH21 ' CD2' ' A' ' 67' ' ' LEU . 3.6 ptt180 -173.69 163.05 4.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.34 1.856 . . . . 0.0 109.467 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 64' ' ' ILE . 3.8 mm? -131.2 -14.52 3.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.306 1.043 . . . . 0.0 111.843 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.57 -56.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 110.217 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.19 -170.98 44.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.354 0.978 . . . . 0.0 112.073 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -59.01 145.48 41.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.388 0.594 . . . . 0.0 109.564 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.79 178.63 35.11 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.817 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -138.69 158.65 69.8 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-N 114.429 -0.886 . . . . 0.0 108.784 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.9 -0.92 5.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.802 3.001 . . . . 0.0 114.721 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.1 m -150.72 156.12 40.68 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 119.881 -1.762 . . . . 0.0 109.361 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.08 -53.3 64.94 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.69 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.23 -36.92 86.37 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.365 2.043 . . . . 0.0 113.178 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.16 -39.78 79.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.0 0.92 . . . . 0.0 109.284 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -76.64 -45.8 28.48 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.361 -0.828 . . . . 0.0 108.957 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.99 -46.16 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.51 1.05 . . . . 0.0 108.867 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.29 -45.23 76.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.964 1.306 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -56.41 -50.44 71.62 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -48.84 77.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.456 1.102 . . . . 0.0 110.799 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.06 -46.14 89.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.734 0.413 . . . . 0.0 110.359 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.8 t -66.94 -56.26 11.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.847 0.859 . . . . 0.0 112.874 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -75.75 -19.5 58.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 62.16 25.96 15.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.023 1.729 . . . . 0.0 111.588 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 91' ' ' THR . 1.2 pt20 -66.62 140.84 96.64 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.19 139.72 42.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.607 -2.113 . . . . 0.0 106.607 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.02 -50.36 5.95 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.04 132.02 8.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -50.23 32.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.833 1.253 . . . . 0.0 111.157 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -50.93 -53.25 34.49 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.36 0.664 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.2 p -69.48 -33.03 72.28 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.15 6.75 54.86 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.207 1.384 . . . . 0.0 113.264 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 53' ' ' VAL . 47.2 t -74.73 149.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.432 1.893 . . . . 0.0 111.591 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.01 142.11 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 107.676 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.56 121.23 27.31 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -106.88 -39.98 5.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.576 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -158.1 144.08 17.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.608 1.549 . . . . 0.0 112.47 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 135.26 35.95 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.398 1.479 . . . . 0.0 110.914 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.53 118.08 69.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.15 130.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.041 2.494 . . . . 0.0 112.446 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.2 t -56.54 -48.18 77.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.279 1.032 . . . . 0.0 109.967 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.82 151.77 5.93 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.06 62.19 7.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.918 3.079 . . . . 0.0 111.478 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 t -72.95 139.83 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.219 -0.926 . . . . 0.0 110.026 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.8 m -74.04 -22.64 59.48 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.944 0.497 . . . . 0.0 111.106 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -151.59 156.13 39.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.489 1.115 . . . . 0.0 108.278 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -72.38 111.64 7.75 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.02 42.23 2.96 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 t -154.29 167.77 28.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.209 1.803 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -120.98 11.82 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.433 2.293 . . . . 0.0 109.188 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.87 103.85 2.9 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -57.58 -30.4 65.25 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.127 0.964 . . . . 0.0 112.013 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.6 t -47.7 -48.64 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.161 1.784 . . . . 0.0 112.448 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.23 -21.46 58.6 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.13 147.74 94.07 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.48 167.93 22.65 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -56.57 -31.13 63.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.051 0.54 . . . . 0.0 110.748 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.6 0.53 1.58 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.093 2.557 . . . . 0.0 113.806 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.27 18.64 4.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.041 1.736 . . . . 0.0 109.871 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -95.87 137.86 34.33 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.24 67.91 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.991 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.8 p-90 -96.55 2.75 52.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.363 1.465 . . . . 0.0 113.462 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -94.46 85.81 4.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 43.5 m-70 -69.75 -17.12 63.42 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.505 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.24 -154.83 21.22 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.75 25.3 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.659 1.583 . . . . 0.0 113.624 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.97 147.71 6.53 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 119.073 0.851 . . . . 0.0 112.867 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.05 163.93 34.25 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.117 2.545 . . . . 0.0 110.953 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -60.0 -31.01 69.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.09 79.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.298 0.954 . . . . 0.0 109.428 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -68.44 -39.18 81.59 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' CD ' ' A' ' 41' ' ' ARG . 76.0 t -63.06 -51.52 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.316 0.646 . . . . 0.0 111.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.57 -44.78 13.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.423 1.089 . . . . 0.0 112.891 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.57 -14.31 61.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.0 -46.35 21.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.06 1.3 . . . . 0.0 110.154 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.61 127.06 31.85 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.6 t -127.57 -29.25 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.206 1.002 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -125.84 158.99 33.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.321 1.048 . . . . 0.0 110.549 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.22 142.25 58.46 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.2 -13.23 66.89 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.613 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -69.14 133.11 47.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -147.39 157.09 43.44 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.778 1.172 . . . . 0.0 113.562 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.96 168.6 24.05 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.86 132.3 71.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 28' ' ' VAL . 45.5 ptt85 -131.83 160.99 34.03 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.94 128.88 45.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 t -71.59 116.72 12.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -48.81 132.39 18.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.707 0.803 . . . . 0.0 111.723 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -58.65 2.68 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.508 1.527 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -61.71 -24.59 66.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.034 1.333 . . . . 0.0 111.704 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 57.85 12.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.273 2.629 . . . . 0.0 115.085 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.98 138.69 42.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.853 1.261 . . . . 0.0 108.19 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -80.37 137.93 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.55 113.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.556 1.142 . . . . 0.0 110.322 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -76.31 116.44 17.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -112.0 123.1 49.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.19 165.51 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -116.32 140.29 49.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.572 1.149 . . . . 0.0 108.164 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -159.8 144.75 15.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.419 1.087 . . . . 0.0 108.803 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 49.24 18.72 0.26 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.121 2.168 . . . . 0.0 114.334 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.35 23.47 37.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.351 0.976 . . . . 0.0 113.082 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -139.5 114.58 8.12 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.572 1.549 . . . . 0.0 110.817 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.52 101.74 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.383 2.055 . . . . 0.0 109.132 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -83.72 157.81 22.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.57 128.91 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -120.63 115.83 24.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.712 1.205 . . . . 0.0 107.93 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.58 139.12 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.59 ' HA ' HD11 ' A' ' 73' ' ' LEU . 28.1 mt -98.48 105.31 17.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -72.63 158.79 34.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 p -141.32 90.78 2.33 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 106.506 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.01 137.72 42.32 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 51.76 34.61 13.42 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.729 0.776 . . . . 0.0 110.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 70.73 -5.03 1.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 128.245 2.618 . . . . 0.0 113.496 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mp -98.45 123.16 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.929 0.892 . . . . 0.0 110.653 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -71.77 128.56 36.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -154.68 157.25 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 109.296 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 64' ' ' ILE . 5.8 mp -131.27 -36.28 1.3 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.311 1.044 . . . . 0.0 111.945 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -20.35 0.06 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.9 -148.15 10.26 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.71 163.67 18.62 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.26 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.89 167.92 12.93 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -136.93 155.51 76.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 124.004 0.922 . . . . 0.0 110.723 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.68 -12.15 32.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.907 3.071 . . . . 0.0 114.198 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -144.34 160.72 40.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.3 -53.26 18.8 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 116.928 -1.511 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.57 -34.04 97.47 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 112.972 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.22 -47.04 84.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.429 1.491 . . . . 0.0 108.369 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 84' ' ' LEU . 1.3 tm? -71.98 -46.48 57.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.43 1.492 . . . . 0.0 110.583 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -53.53 -44.31 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.77 0.714 . . . . 0.0 110.342 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.36 -30.51 71.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -71.13 -41.6 70.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.364 0.529 . . . . 0.0 109.696 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.8 -38.82 90.02 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 111.414 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.82 -42.01 86.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.538 1.135 . . . . 0.0 108.798 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -72.69 -52.01 17.0 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.507 1.049 . . . . 0.0 112.126 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.6 p -71.43 -20.36 62.12 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.272 -0.892 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 56.82 29.97 16.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.218 1.007 . . . . 0.0 109.026 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -72.76 137.05 80.03 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.9 131.7 14.72 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.1 mt -49.1 -41.03 34.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.865 2.066 . . . . 0.0 111.318 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -145.59 137.92 25.66 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.65 -40.04 84.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -42.98 -42.94 3.95 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 127.106 2.162 . . . . 0.0 112.94 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -110.71 -49.97 2.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.311 1.044 . . . . 0.0 109.959 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.86 9.74 42.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.791 1.186 . . . . 0.0 113.155 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.1 t -59.66 134.3 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 124.803 1.241 . . . . 0.0 113.127 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.37 152.76 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.457 1.903 . . . . 0.0 106.583 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.1 132.15 37.49 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -116.33 -38.51 3.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.012 0.824 . . . . 0.0 111.456 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.28 142.29 3.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -79.96 175.75 10.35 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.097 0.475 . . . . 0.0 110.779 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.55 120.62 30.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.02 129.54 11.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.628 2.885 . . . . 0.0 112.474 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 10.4 t -58.0 -52.8 64.0 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.359 1.464 . . . . 0.0 112.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.39 -149.67 49.91 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.23 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.2 134.69 29.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.989 2.459 . . . . 0.0 111.391 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 p -132.49 141.67 48.88 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.67 1.988 . . . . 0.0 107.359 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 m -83.51 -11.37 57.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.474 0.579 . . . . 0.0 111.648 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 C-N-CA 129.212 3.291 . . . . 0.0 105.381 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.742 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.6 80.64 1.74 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.776 0.83 . . . . 0.0 111.333 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 t -145.31 -177.38 5.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.567 1.547 . . . . 0.0 107.489 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.22 -144.49 8.71 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 120.996 -1.065 . . . . 0.0 111.833 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -70.29 88.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 108.607 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -142.02 154.2 44.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.984 0.914 . . . . 0.0 109.115 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.68 78.68 1.89 Allowed Glycine 0 C--N 1.331 0.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.75 -33.28 34.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.51 1.524 . . . . 0.0 111.308 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.47 -31.3 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.071 1.349 . . . . 0.0 110.917 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.86 -11.51 58.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.934 0.894 . . . . 0.0 112.514 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -71.65 154.12 93.2 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 119.417 1.008 . . . . 0.0 109.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.48 159.17 54.57 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.5 tt -54.2 -35.65 62.59 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.631 -0.668 . . . . 0.0 112.57 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -64.75 -14.12 57.62 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.23 -1.72 26.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.32 1.448 . . . . 0.0 110.638 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -72.19 140.48 48.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 121.689 -0.632 . . . . 0.0 111.428 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -59.69 -24.18 63.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.327 1.051 . . . . 0.0 111.406 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -94.49 0.7 55.51 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.646 1.578 . . . . 0.0 113.824 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' HD21 ' A' ' 13' ' ' LEU . 62.5 t80 -88.74 95.85 10.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -85.46 -11.42 54.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.03 -157.24 15.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.688 1.137 . . . . 0.0 111.012 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 22.44 1.66 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.14 1.376 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -48.26 137.9 11.22 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.563 1.545 . . . . 0.0 114.636 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.91 168.05 22.76 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.061 2.507 . . . . 0.0 109.444 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -58.85 -23.16 60.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.42 87.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.065 0.848 . . . . 0.0 110.701 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.98 -43.4 58.25 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.145 0.498 . . . . 0.0 110.147 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.1 t -52.71 -39.09 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 126.812 2.045 . . . . 0.0 111.772 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.29 62.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.713 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -100.21 -5.53 27.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.133 0.973 . . . . 0.0 112.162 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.5 mt -87.05 -37.74 17.18 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.185 -0.947 . . . . 0.0 110.656 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.46 131.68 36.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.84 -23.9 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -135.27 160.36 38.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.825 -1.172 . . . . 0.0 110.716 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.1 p -64.02 142.84 58.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.48 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.84 -12.46 67.29 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 117.764 -1.576 . . . . 0.0 111.722 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.54 143.87 54.77 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 27.8 p90 -149.42 160.64 43.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.232 1.015 . . . . 0.0 111.473 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 171.96 19.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.716 2.006 . . . . 0.0 107.769 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.12 154.89 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -149.12 142.97 25.69 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -79.87 161.04 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.88 169.55 5.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.539 0.736 . . . . 0.0 109.19 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.69 -16.93 59.53 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.17 -37.85 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.139 1.352 . . . . 0.0 111.246 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -69.12 145.57 53.24 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.032 -0.687 . . . . 0.0 110.13 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 47' ' ' GLN . 5.9 pm0 -81.64 52.47 1.9 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.94 102.0 6.32 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.93 1.692 . . . . 0.0 111.181 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -63.06 149.98 43.72 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.342 1.068 . . . . 0.0 111.211 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.8 t -132.21 125.22 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.092 1.757 . . . . 0.0 109.186 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -86.34 135.26 33.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -125.97 128.12 46.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.04 162.35 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 tp -112.56 137.44 50.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -156.9 136.7 12.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t70 54.75 27.4 8.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.873 0.869 . . . . 0.0 111.725 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.14 4.44 72.96 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.924 1.725 . . . . 0.0 114.723 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.71 118.45 41.03 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 119.794 1.797 . . . . 0.0 109.919 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.74 102.93 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.28 2.653 . . . . 0.0 111.974 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -80.57 123.58 28.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.259 1.424 . . . . 0.0 108.692 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -99.99 131.59 45.86 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.411 ' CE2' HD13 ' A' ' 95' ' ' LEU . 98.1 m-85 -126.82 100.5 6.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.788 1.235 . . . . 0.0 108.383 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.36 126.81 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.42 143.78 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -113.55 137.04 52.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 p -123.57 141.4 52.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -170.08 150.47 3.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.35 38.22 21.06 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.474 1.11 . . . . 0.0 112.273 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 63.75 12.08 6.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.272 1.429 . . . . 0.0 113.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.0 mp -121.37 166.97 13.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.489 1.516 . . . . 0.0 108.387 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -119.58 140.09 51.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.09 -173.06 4.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.84 1.256 . . . . 0.0 108.88 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.8 -49.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.169 0.587 . . . . 0.0 111.502 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.44 -20.48 2.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.2 -112.77 0.35 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -50.17 145.14 6.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.471 1.509 . . . . 0.0 112.954 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.75 175.66 21.14 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 125.096 1.332 . . . . 0.0 109.875 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -144.64 163.53 33.23 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.13 -11.23 26.59 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.524 2.816 . . . . 0.0 114.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 153.19 37.87 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.739 1.154 . . . . 0.0 108.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 mm -56.16 -50.07 89.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.394 -1.289 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.51 -28.61 61.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 121.211 1.468 . . . . 0.0 114.767 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.41 -46.67 87.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.06 -45.16 86.46 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.963 -0.542 . . . . 0.0 109.611 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.75 -49.34 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.38 -37.74 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.702 0.683 . . . . 0.0 111.615 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -64.91 -52.08 58.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.592 0.357 . . . . 0.0 110.263 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.07 -35.97 74.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.845 0.748 . . . . 0.0 112.109 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.88 -49.59 44.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.493 1.117 . . . . 0.0 109.095 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 t -66.06 -26.39 67.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.636 1.174 . . . . 0.0 112.6 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.7 p -98.9 -25.71 14.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 61.09 25.83 15.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.851 1.66 . . . . 0.0 110.545 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -73.91 157.37 87.24 Favored Pre-proline 0 C--O 1.24 0.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.907 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.23 147.45 33.09 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' CE2' ' A' ' 62' ' ' PHE . 4.5 mt -60.48 -46.46 90.01 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.981 2.512 . . . . 0.0 111.149 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 35.2 p -151.02 136.86 18.1 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.561 1.544 . . . . 0.0 107.415 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -36.41 65.88 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.695 0.798 . . . . 0.0 112.127 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -65.13 -7.67 13.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.248 -1.358 . . . . 0.0 114.523 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p -136.6 -20.84 1.33 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 121.384 1.902 . . . . 0.0 113.852 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.3 18.68 63.31 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.716 -1.047 . . . . 0.0 113.822 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.3 t -72.22 137.64 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 119.332 1.566 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.74 148.28 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.09 112.58 24.54 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -89.32 -44.79 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.327 0.512 . . . . 0.0 110.136 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -159.89 151.81 20.39 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.293 -0.88 . . . . 0.0 110.119 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.72 144.0 28.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.432 1.093 . . . . 0.0 110.389 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.77 121.5 71.88 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -72.6 150.3 50.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.202 1.935 . . . . 0.0 110.704 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -67.06 -49.23 65.8 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.148 0.979 . . . . 0.0 109.078 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 149.82 -167.85 29.92 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.7 13.66 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.224 3.283 . . . . 0.0 114.228 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 p -58.03 168.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.942 1.697 . . . . 0.0 113.456 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -71.0 162.17 29.88 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.734 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -173.76 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -143.82 153.83 42.77 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.74 154.0 25.65 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -80.54 -172.98 3.86 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.586 2.354 . . . . 0.0 112.541 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -132.11 135.22 46.26 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.048 1.739 . . . . 0.0 106.487 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.83 81.22 1.24 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 106.051 -2.819 . . . . 0.0 106.051 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -48.69 -36.71 16.76 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.73 2.012 . . . . 0.0 113.273 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.57 -26.89 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.065 -0.397 . . . . 0.0 111.764 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -74.73 -13.61 60.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.752 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.22 140.23 83.44 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.05 151.25 85.7 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.149 -1.135 . . . . 0.0 109.149 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.5 tt -53.85 -34.86 60.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -66.38 -15.13 63.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.494 1.043 . . . . 0.0 113.45 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.19 -5.24 23.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.237 1.815 . . . . 0.0 110.226 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -66.87 131.09 45.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.808 -0.558 . . . . 0.0 110.826 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.71 -11.04 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -103.48 -2.8 26.26 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.451 1.478 . . . . 0.0 111.107 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 13' ' ' LEU . 41.2 t80 -84.86 94.74 8.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 47.0 m-70 -83.51 -6.99 59.61 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -162.61 30.82 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.238 -0.913 . . . . 0.0 111.566 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 43.03 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.966 1.706 . . . . 0.0 113.808 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 pt -72.42 148.99 91.09 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 120.134 -1.604 . . . . 0.0 112.402 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 55.3 Cg_endo -77.8 156.64 31.27 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.112 3.208 . . . . 0.0 112.243 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -58.42 -32.96 69.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 -31.73 72.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.197 0.311 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 61.7 mm-40 -87.03 -32.49 19.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.83 -45.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.18 -19.24 12.77 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.96 -13.01 45.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.272 0.942 . . . . 0.0 112.933 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 107' ' ' VAL . 91.9 mt -81.99 -51.02 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.087 1.355 . . . . 0.0 111.315 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -82.28 131.8 35.23 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.599 0.76 . . . . 0.0 109.057 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 t -134.02 -29.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.767 0.827 . . . . 0.0 111.698 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -118.34 126.54 52.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.574 1.55 . . . . 0.0 109.814 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.6 p -45.22 112.36 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.758 1.623 . . . . 0.0 110.369 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.1 -18.98 5.5 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 118.794 0.725 . . . . 0.0 111.465 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -73.67 129.8 38.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.979 2.112 . . . . 0.0 106.562 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -139.08 161.55 37.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.092 1.357 . . . . 0.0 111.336 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.71 167.32 30.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.489 1.516 . . . . 0.0 111.069 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.51 143.22 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 110.972 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -139.71 162.6 34.73 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -101.16 138.78 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.314 1.046 . . . . 0.0 109.379 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -69.37 139.55 54.18 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.811 0.815 . . . . 0.0 109.753 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -47.13 -44.65 21.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.278 3.031 . . . . 0.0 116.926 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.78 -23.76 2.71 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.51 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -81.43 -175.5 5.53 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.423 1.111 . . . . 0.0 108.121 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -128.77 54.91 1.75 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -138.56 141.14 39.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.265 1.426 . . . . 0.0 110.724 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -90.43 161.27 15.63 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.319 1.057 . . . . 0.0 111.348 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.97 140.69 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.088 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.9 tp -105.15 124.99 50.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -113.24 134.07 54.77 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 101' ' ' VAL . 1.7 m -141.86 165.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.1 tp -124.27 154.14 40.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -152.56 -85.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.972 -1.08 . . . . 0.0 110.714 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -79.24 23.85 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.852 2.061 . . . . 0.0 112.871 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.45 -8.1 66.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.872 1.225 . . . . 0.0 113.785 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.59 120.14 41.77 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 124.982 1.313 . . . . 0.0 107.726 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.62 92.66 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.237 1.958 . . . . 0.0 109.445 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -63.08 119.86 10.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.64 1.976 . . . . 0.0 109.602 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -97.4 125.27 41.92 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -117.27 114.47 23.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.843 0.857 . . . . 0.0 109.342 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.69 119.08 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.95 107.41 2.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -65.08 150.06 48.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 t -149.55 111.67 4.64 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.9 tp -130.09 -81.06 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.524 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.73 37.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.155 1.382 . . . . 0.0 112.895 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.9 m120 67.86 13.32 9.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.615 1.566 . . . . 0.0 111.14 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.83 154.63 40.72 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.352 2.261 . . . . 0.0 107.575 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -115.15 140.07 49.39 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.48 1.512 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.9 ptt180 -176.2 168.35 2.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.535 1.534 . . . . 0.0 111.184 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.33 -36.78 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -158.83 124.77 4.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.429 1.492 . . . . 0.0 108.891 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.68 -150.52 20.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -65.63 168.1 8.07 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.933 0.866 . . . . 0.0 109.995 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 72' ' ' ARG . . . -128.28 -177.31 14.81 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -138.21 158.64 70.57 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 117.185 0.492 . . . . 0.0 110.568 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.49 -17.14 58.66 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 113.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.8 162.35 35.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.8 0.809 . . . . 0.0 111.379 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.02 -50.9 82.73 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.888 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.31 -38.8 32.87 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.827 1.685 . . . . 0.0 113.146 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -46.53 70.83 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.545 1.138 . . . . 0.0 109.879 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.56 -56.28 15.01 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.317 0.647 . . . . 0.0 109.605 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -48.69 -46.21 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.675 0.79 . . . . 0.0 110.3 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.55 -42.49 95.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 112.254 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.07 -45.79 92.0 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.107 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.54 -49.1 76.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.508 1.523 . . . . 0.0 109.864 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -55.35 -33.13 63.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 109.993 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.4 t -80.96 -47.5 13.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.854 0.752 . . . . 0.0 110.638 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.5 p -66.77 -22.86 66.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.074 1.307 . . . . 0.0 112.635 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 58.82 25.81 14.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.502 1.521 . . . . 0.0 112.159 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.38 166.01 43.07 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.741 1.616 . . . . 0.0 112.377 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -85.54 137.41 5.82 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 121.681 1.587 . . . . 0.0 108.779 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mt -50.93 -44.65 60.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.825 2.05 . . . . 0.0 110.403 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.3 p -152.66 152.46 31.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.813 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -65.05 -27.45 68.79 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.456 1.025 . . . . 0.0 110.767 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -78.41 -20.79 50.37 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.129 1.371 . . . . 0.0 112.924 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -145.66 91.35 2.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.38 37.87 0.57 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.915 1.722 . . . . 0.0 113.262 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 99' ' ' SER . 67.3 t -72.11 141.07 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 128.503 2.721 . . . . 0.0 106.07 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.77 139.41 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.52 114.94 14.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -105.79 -37.11 6.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.906 0.775 . . . . 0.0 109.427 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -155.66 141.61 18.18 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.038 0.836 . . . . 0.0 110.576 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.51 132.77 34.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 31' ' ' LEU . 78.1 t -75.83 116.67 57.51 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.9 138.4 44.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.701 1.6 . . . . 0.0 110.539 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.492 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 29.9 p -72.11 -31.02 65.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.46 1.104 . . . . 0.0 113.025 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.82 -174.98 13.71 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.311 1.91 . . . . 0.0 111.003 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.49 162.11 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.513 2.808 . . . . 0.0 113.749 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -158.92 155.18 27.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.484 1.114 . . . . 0.0 109.758 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -82.74 -67.13 0.81 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 110.429 179.398 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -140.25 166.14 25.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.48 0.712 . . . . 0.0 111.284 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -108.46 -151.6 0.47 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.795 2.038 . . . . 0.0 110.235 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.96 -21.89 37.25 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 125.005 1.288 . . . . 0.0 113.827 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -100.14 117.89 35.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.869 1.268 . . . . 0.0 113.031 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -133.55 179.96 5.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.019 1.728 . . . . 0.0 107.591 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.09 12.33 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.954 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -52.04 -33.94 40.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.802 1.241 . . . . 0.0 113.347 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.88 -26.31 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 121.342 -0.849 . . . . 0.0 111.218 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.62 -8.63 59.59 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.197 -0.939 . . . . 0.0 111.59 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -65.03 146.56 98.9 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 120.049 1.295 . . . . 0.0 109.905 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -68.19 157.51 61.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 N-CA-C 106.425 -2.183 . . . . 0.0 106.425 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.62 -31.49 64.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.163 -0.961 . . . . 0.0 112.151 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -67.14 -9.63 41.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.297 0.953 . . . . 0.0 113.414 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -106.12 -4.57 20.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.25 1.42 . . . . 0.0 111.373 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -73.44 142.43 46.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.694 0.759 . . . . 0.0 112.207 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -59.29 -46.7 87.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.834 1.654 . . . . 0.0 111.156 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -72.26 -11.58 60.78 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 112.836 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -88.4 90.65 8.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.797 1.18 . . . . 0.0 110.257 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -67.04 -37.54 84.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.482 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.39 103.18 1.48 Allowed Glycine 0 C--N 1.337 0.599 0 O-C-N 121.931 -0.48 . . . . 0.0 114.16 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 38.89 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.14 3.385 . . . . 0.0 120.14 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.93 155.8 14.62 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.173 1.789 . . . . 0.0 112.51 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.27 155.47 32.81 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.711 2.941 . . . . 0.0 110.472 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -56.12 -25.88 47.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.29 83.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.841 0.746 . . . . 0.0 110.361 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.65 -21.48 60.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.421 0.555 . . . . 0.0 111.026 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.76 -45.56 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 120.704 -1.247 . . . . 0.0 109.163 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 -22.16 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -91.61 -25.33 19.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.231 1.378 . . . . 0.0 112.292 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 107' ' ' VAL . 81.5 mt -69.65 -44.64 70.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.238 1.415 . . . . 0.0 114.213 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.25 132.09 36.38 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -122.4 -27.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -132.79 165.07 25.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.875 1.27 . . . . 0.0 110.917 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -74.95 131.31 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.55 -12.74 27.89 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.42 136.76 35.7 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.217 1.407 . . . . 0.0 107.302 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -144.21 162.17 37.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.527 2.331 . . . . 0.0 111.227 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.13 163.29 37.74 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.497 2.319 . . . . 0.0 109.564 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.48 140.06 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 120.527 -1.358 . . . . 0.0 108.978 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -132.3 172.48 12.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -121.54 125.04 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.476 1.11 . . . . 0.0 108.525 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -56.08 140.93 42.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.737 1.215 . . . . 0.0 109.827 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 142.62 57.9 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.14 8.46 4.75 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -158.08 130.06 6.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 121.53 2.665 . . . . 0.0 108.396 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -71.69 77.78 0.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -129.75 101.95 6.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.83 146.8 47.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.16 127.02 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.87 99.57 11.6 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.894 1.678 . . . . 0.0 106.711 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 t -100.48 125.85 46.84 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -134.87 160.07 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 118.99 0.814 . . . . 0.0 109.653 178.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.6 tp -110.43 138.07 47.3 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.095 0.958 . . . . 0.0 108.942 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -159.82 139.26 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 55.7 2.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.484 1.914 . . . . 0.0 115.71 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.59 41.47 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.523 2.011 . . . . 0.0 111.901 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.09 105.0 56.91 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 118.605 1.202 . . . . 0.0 110.494 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.85 108.5 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.184 1.923 . . . . 0.0 107.367 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -84.16 151.55 24.81 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.63 2.372 . . . . 0.0 110.039 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -127.8 117.31 21.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -114.59 102.03 9.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.5 mt -66.55 117.13 6.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 70.9 mt -66.15 116.25 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.82 132.91 35.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -118.36 102.8 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD11 ' HE ' ' A' ' 72' ' ' ARG . 4.6 pp -144.39 160.43 41.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.623 1.169 . . . . 0.0 109.242 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 t0 49.95 22.96 0.97 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.886 1.674 . . . . 0.0 114.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 77.1 17.06 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.953 2.501 . . . . 0.0 111.626 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -129.66 179.01 6.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.146 2.179 . . . . 0.0 108.925 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -127.21 129.1 47.17 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.082 1.753 . . . . 0.0 107.944 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HE ' HD11 ' A' ' 67' ' ' LEU . 26.2 ptt180 -165.14 169.79 15.72 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 124.194 0.998 . . . . 0.0 110.325 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.26 -78.7 0.6 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -136.17 88.6 2.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.946 1.698 . . . . 0.0 106.736 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.37 -173.72 24.91 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.243 1.878 . . . . 0.0 110.19 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.87 160.96 6.99 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.94 -173.35 13.88 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -146.57 164.1 26.0 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.493 0.717 . . . . 0.0 109.912 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.3 -9.19 22.91 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.76 3.64 . . . . 0.0 114.767 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 t -146.55 158.61 43.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.649 1.113 . . . . 0.0 108.785 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mm -62.8 -49.66 81.23 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.558 -1.21 . . . . 0.0 110.576 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.12 -32.76 63.24 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.491 1.568 . . . . 0.0 113.812 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.31 -44.57 92.54 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.33 -54.85 14.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.216 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.52 -49.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.319 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.92 -35.24 74.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.731 0.696 . . . . 0.0 111.663 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -63.81 -42.97 97.59 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.738 0.699 . . . . 0.0 109.834 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.68 -36.19 75.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.73 0.696 . . . . 0.0 109.859 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.74 -38.67 89.78 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.9 t -70.43 -65.17 0.76 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.629 0.772 . . . . 0.0 109.833 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 p -68.04 -15.04 63.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 59.89 29.57 19.13 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 111.253 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.63 138.46 83.25 Favored Pre-proline 0 C--O 1.236 0.357 0 O-C-N 121.52 -0.738 . . . . 0.0 109.195 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.4 151.96 48.74 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.11 1.874 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.26 -35.68 74.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.872 0.869 . . . . 0.0 109.845 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -177.53 141.89 0.31 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.687 1.595 . . . . 0.0 107.586 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -17.68 64.06 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.926 -0.484 . . . . 0.0 109.874 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -57.94 -25.1 60.47 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.488 1.115 . . . . 0.0 110.244 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 p -134.14 -10.61 2.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.006 0.922 . . . . 0.0 112.908 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.69 -0.06 1.77 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.724 2.107 . . . . 0.0 116.773 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -57.6 135.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 127.571 2.349 . . . . 0.0 112.229 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.71 157.53 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.923 1.689 . . . . 0.0 107.806 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.19 113.4 24.99 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -97.99 -42.55 7.46 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -164.07 154.04 14.66 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.533 0.606 . . . . 0.0 110.086 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.02 172.87 12.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.404 1.081 . . . . 0.0 110.368 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 31' ' ' LEU . 18.3 t -115.5 105.35 52.23 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.57 132.32 15.89 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.297 1.998 . . . . 0.0 109.65 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.4 p -56.62 -54.96 39.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.048 0.939 . . . . 0.0 112.939 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.72 150.48 7.37 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.88 -14.14 21.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 114.686 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.9 m -61.95 -23.12 66.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -135.42 18.15 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.52 1.128 . . . . 0.0 110.899 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -79.51 15.18 1.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -55.84 162.95 1.59 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.49 76.82 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -98.82 103.1 15.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.378 -2.452 . . . . 0.0 104.378 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -149.85 163.28 38.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.02 113.45 3.98 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 104.561 -3.416 . . . . 0.0 104.561 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -46.83 -37.57 8.92 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.62 2.368 . . . . 0.0 112.465 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -52.81 -37.98 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.746 0.819 . . . . 0.0 111.78 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -69.62 -19.86 63.62 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -65.59 147.23 98.8 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 111.477 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 153.03 79.64 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 106.149 -2.289 . . . . 0.0 106.149 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.54 -36.97 62.4 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.95 -8.3 35.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -102.41 -5.8 23.7 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.87 1.268 . . . . 0.0 108.899 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -75.81 133.03 40.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.94 -35.07 61.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 112.336 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -85.46 0.07 53.4 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.094 1.358 . . . . 0.0 114.665 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.98 89.34 7.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -75.0 -9.55 58.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.35 -150.39 19.59 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.495 1.498 . . . . 0.0 111.296 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.44 18.88 3.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.998 1.399 . . . . 0.0 114.111 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -40.34 136.83 1.35 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.875 1.27 . . . . 0.0 113.891 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.31 163.61 35.97 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.53 2.153 . . . . 0.0 111.9 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -55.07 -36.43 65.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.32 74.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.011 0.819 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.16 -40.34 18.3 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.667 0.787 . . . . 0.0 109.754 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.64 -50.57 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.48 0.712 . . . . 0.0 109.082 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -15.64 4.73 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.863 1.665 . . . . 0.0 114.878 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -88.89 -33.59 17.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.038 0.836 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HB3' HG11 ' A' ' 107' ' ' VAL . 27.4 mt -69.6 -49.93 49.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 126.045 1.738 . . . . 0.0 113.498 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -73.96 139.27 44.73 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.21 -35.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.077 0.951 . . . . 0.0 112.464 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -121.51 159.51 26.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.164 0.983 . . . . 0.0 113.642 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -61.09 124.34 20.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.012 0.925 . . . . 0.0 108.679 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.11 50.03 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.378 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -66.47 131.11 45.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 17.3 p90 -140.17 154.1 46.84 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.383 1.073 . . . . 0.0 111.825 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.68 160.25 43.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.057 1.743 . . . . 0.0 110.18 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.83 138.76 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 45.2 ptt85 -138.77 165.83 25.97 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.349 0.405 . . . . 0.0 110.291 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.35 140.9 29.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.384 1.873 . . . . 0.0 108.053 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.8 t -79.8 113.8 18.24 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -41.77 107.51 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.507 1.923 . . . . 0.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.12 -10.27 56.75 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 117.616 -1.658 . . . . 0.0 116.964 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 179.96 6.61 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 121.349 2.575 . . . . 0.0 110.892 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -103.3 33.85 3.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 111.585 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -100.62 103.32 14.61 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.548 1.539 . . . . 0.0 107.104 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -70.87 158.28 36.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.927 -0.483 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.65 140.32 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.523 1.129 . . . . 0.0 109.54 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 103.34 12.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 t -106.43 124.41 49.55 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.83 168.15 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.171 0.896 . . . . 0.0 108.924 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.09 146.22 46.97 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.602 1.161 . . . . 0.0 108.288 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.659 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.3 t-105 -149.2 -63.35 0.23 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.641 0.257 . . . . 0.0 111.201 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -107.24 42.53 1.3 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.931 0.892 . . . . 0.0 112.518 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.61 -1.41 29.29 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.217 -0.927 . . . . 0.0 112.74 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.46 113.28 36.83 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 128.107 2.563 . . . . 0.0 106.118 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.85 110.78 2.45 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.382 1.388 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' HG21 ' A' ' 101' ' ' VAL . 25.3 mmt180 -75.28 115.95 15.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -97.91 116.03 29.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.06 139.1 42.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -90.07 110.3 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.06 125.04 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.42 149.42 25.02 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.1 p -146.01 101.14 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.28 -5.09 0.33 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.52 27.22 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.27 10.17 4.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.354 1.462 . . . . 0.0 109.436 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.8 126.19 28.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.835 2.054 . . . . 0.0 106.352 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -77.87 132.92 38.19 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 177.96 8.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.6 tp -150.9 -32.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.589 1.156 . . . . 0.0 109.155 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.2 -71.81 0.74 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.19 -72.52 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 CA-C-N 118.777 0.717 . . . . 0.0 111.394 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.49 138.82 54.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.237 0.519 . . . . 0.0 109.62 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.12 19.53 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -142.47 159.07 59.13 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.19 -11.72 32.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.352 3.368 . . . . 0.0 113.464 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.1 m -147.04 166.56 26.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.527 1.131 . . . . 0.0 109.017 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.96 -55.12 4.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.196 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.91 -30.81 87.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 121.198 1.464 . . . . 0.0 112.4 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.7 -48.3 81.57 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.261 1.824 . . . . 0.0 109.13 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.16 -47.45 61.6 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.03 -42.94 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.945 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.91 -40.66 91.7 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.431 0.559 . . . . 0.0 110.415 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -59.11 -40.73 86.28 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.47 -49.35 49.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.169 0.895 . . . . 0.0 109.242 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.34 -31.29 61.59 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.993 0.517 . . . . 0.0 109.969 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.7 t -82.08 -60.96 2.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.285 1.434 . . . . 0.0 110.894 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.0 p -67.0 -20.92 65.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 115.132 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 58.96 26.66 15.28 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.322 1.449 . . . . 0.0 111.392 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.11 146.06 92.08 Favored Pre-proline 0 C--O 1.237 0.428 0 O-C-N 121.761 -0.587 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.44 133.64 13.28 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 121.706 1.604 . . . . 0.0 108.277 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.6 -41.1 63.37 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.916 0.886 . . . . 0.0 111.832 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.61 146.15 24.96 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.5 -41.1 89.1 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -59.14 -55.6 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.657 0.662 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -45.64 93.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 123.571 0.544 . . . . 0.0 110.205 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 -6.33 6.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.489 1.518 . . . . 0.0 113.413 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG22 ' CG ' ' A' ' 55' ' ' TRP . 72.9 t -64.2 142.54 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 130.599 3.559 . . . . 0.0 111.067 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 t -129.33 161.48 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 127.589 2.356 . . . . 0.0 107.808 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 124.95 43.24 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -111.92 -38.44 4.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.117 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.58 151.87 15.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -96.84 153.49 17.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 31' ' ' LEU . 42.3 t -97.23 125.43 45.66 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.88 158.76 11.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.33 2.02 . . . . 0.0 112.487 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.72 -16.63 29.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.584 1.154 . . . . 0.0 110.774 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.89 115.38 3.16 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.681 -1.066 . . . . 0.0 112.623 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.57 -3.56 11.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.04 3.827 . . . . 0.0 113.544 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.8 t -61.83 -28.08 69.23 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.46 1.027 . . . . 0.0 109.617 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -55.04 102.72 0.07 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.718 2.407 . . . . 0.0 109.859 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 C-N-CA 125.29 1.424 . . . . 0.0 110.701 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -166.68 164.98 16.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.366 1.867 . . . . 0.0 106.208 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -75.45 -169.58 1.04 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.598 0.759 . . . . 0.0 109.548 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.98 -146.88 18.05 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 120.828 -1.17 . . . . 0.0 114.765 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 t -149.8 85.95 1.44 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.752 1.221 . . . . 0.0 109.074 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -62.16 -27.78 69.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.493 0.717 . . . . 0.0 112.905 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.22 142.91 6.21 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 106.604 -2.599 . . . . 0.0 106.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 3.3 mt-10 -64.67 -48.11 75.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -51.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.258 1.023 . . . . 0.0 112.893 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.83 -21.99 65.17 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -71.7 141.29 84.73 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.81 159.21 53.8 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 3.0 tt -54.07 -36.42 63.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.475 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -66.28 -6.51 14.19 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.56 -7.3 15.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.719 1.145 . . . . 0.0 110.293 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -70.91 148.03 48.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 122.365 1.078 . . . . 0.0 113.627 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.29 -45.06 85.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.708 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 4.6 p-90 -78.7 3.16 17.25 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.693 1.997 . . . . 0.0 116.373 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 43.3 t80 -94.54 98.7 11.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -88.54 -20.3 25.24 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.42 -157.52 25.77 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 122.351 0.973 . . . . 0.0 114.411 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.91 26.68 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.972 2.509 . . . . 0.0 115.473 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 pt -57.46 152.82 31.41 Favored Pre-proline 0 N--CA 1.471 0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 112.042 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 162.81 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 121.604 1.609 . . . . 0.0 109.812 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -65.59 -18.24 65.18 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.605 -1.309 . . . . 0.0 109.513 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.17 79.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.139 1.375 . . . . 0.0 110.312 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.68 -31.58 24.06 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 124.05 0.844 . . . . 0.0 112.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -47.42 -54.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 119.36 0.982 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -13.63 19.8 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -93.66 -14.26 26.61 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.012 1.325 . . . . 0.0 110.856 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.91 -48.24 10.21 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.383 1.073 . . . . 0.0 109.197 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.77 142.77 38.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 t -120.33 -36.87 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.314 0.646 . . . . 0.0 109.85 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.63 164.56 27.58 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.501 0.667 . . . . 0.0 112.526 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.9 m -59.19 136.19 57.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . 101.28 -18.15 54.48 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 118.501 -1.166 . . . . 0.0 112.25 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -68.81 142.1 54.96 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.0 p90 -146.51 164.75 31.56 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -156.91 159.08 37.78 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.7 1.6 . . . . 0.0 109.52 178.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.4 t -111.69 134.52 53.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.11 143.12 32.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -80.02 156.93 26.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -63.09 177.89 0.55 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.213 1.369 . . . . 0.0 112.041 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -59.93 -47.12 87.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.012 -1.055 . . . . 0.0 109.778 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.36 32.0 1.26 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-O 118.91 -0.939 . . . . 0.0 111.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.35 147.05 45.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.639 1.22 . . . . 0.0 110.846 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.65 64.0 0.88 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.15 2.98 . . . . 0.0 108.479 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -144.47 124.02 13.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.66 1.184 . . . . 0.0 109.405 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.55 145.93 25.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.56 138.71 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.15 111.87 23.78 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 m -102.95 125.17 49.59 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.63 162.36 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.05 137.26 45.46 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -155.67 124.88 6.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 t0 58.56 20.78 7.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.26 1.824 . . . . 0.0 113.774 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.89 0.79 65.96 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.203 1.382 . . . . 0.0 113.302 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 HH11 ' A' ' 60' ' ' ARG . 20.6 tp -112.01 117.71 47.58 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.211 1.405 . . . . 0.0 110.214 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.6 108.96 2.66 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.476 HH11 HD23 ' A' ' 58' ' ' LEU . 14.4 mmm180 -81.11 130.46 35.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.072 3.349 . . . . 0.0 111.114 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -103.51 142.45 34.25 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -130.64 114.12 15.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.2 mt -76.91 94.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mt -60.08 112.0 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -84.22 165.7 18.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -136.46 99.4 4.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.74 1.616 . . . . 0.0 106.899 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 tp -122.84 130.53 52.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.69 0.796 . . . . 0.0 110.096 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.63 18.0 3.4 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 91.9 2.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.472 3.509 . . . . 0.0 112.514 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.94 130.64 56.96 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.17 1.388 . . . . 0.0 109.155 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -81.52 129.42 34.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.509 -0.757 . . . . 0.0 111.076 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -152.92 171.24 18.63 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.2 -83.9 0.61 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.712 1.605 . . . . 0.0 109.742 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.93 9.86 6.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.275 1.03 . . . . 0.0 111.406 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.71 -171.04 12.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -60.96 162.71 6.64 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.501 0.721 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.92 175.81 16.34 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 124.292 0.949 . . . . 0.0 112.622 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.82 159.44 59.61 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 110.94 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.69 -1.35 5.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.683 3.589 . . . . 0.0 114.219 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.3 m -151.85 158.96 43.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.698 -1.251 . . . . 0.0 109.269 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.59 -54.21 31.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.006 -1.473 . . . . 0.0 111.701 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 -38.96 75.06 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.158 1.905 . . . . 0.0 112.577 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -50.14 -38.29 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.797 1.639 . . . . 0.0 110.485 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.07 -49.8 7.52 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.1 mm -46.9 -54.0 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 119.741 1.155 . . . . 0.0 110.743 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.29 -37.44 67.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.33 0.652 . . . . 0.0 111.287 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.22 -43.12 99.39 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.654 -0.654 . . . . 0.0 110.923 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.63 -37.84 80.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.395 0.543 . . . . 0.0 109.634 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.46 -43.37 98.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.0 m -65.62 -54.94 20.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.499 0.59 . . . . 0.0 112.447 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -78.27 -17.36 56.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 63.17 24.07 14.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.244 1.817 . . . . 0.0 111.655 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -61.87 126.18 86.63 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 109.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.07 146.75 29.31 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.235 1.29 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.83 -39.96 83.81 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.98 1.712 . . . . 0.0 111.869 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.6 p -148.05 127.87 13.47 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.703 0.683 . . . . 0.0 110.341 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -57.51 -41.22 80.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.903 1.281 . . . . 0.0 110.984 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.66 -16.48 49.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.762 -1.114 . . . . 0.0 113.69 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 -4.9 3.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.456 1.48 . . . . 0.0 112.708 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.28 19.79 8.89 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.918 1.723 . . . . 0.0 115.523 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -60.05 128.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 119.574 1.687 . . . . 0.0 111.708 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.65 157.16 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.636 1.574 . . . . 0.0 108.303 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.72 111.58 22.99 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.416 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 13.0 m-70 -89.4 -47.82 7.75 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -166.14 154.59 10.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.443 1.897 . . . . 0.0 106.675 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -88.65 -177.24 5.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 39' ' ' LEU . 4.2 m -118.96 131.3 24.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 166.18 15.68 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.314 2.01 . . . . 0.0 111.366 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.8 t -101.0 -34.73 9.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.793 0.837 . . . . 0.0 110.333 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.38 -119.99 5.7 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 118.081 1.992 . . . . 0.0 118.081 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.26 38.43 0.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 1 C-N-CA 126.553 4.835 . . . . 0.0 116.298 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -57.34 -36.28 70.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.542 1.137 . . . . 0.0 111.598 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -132.51 -175.8 3.88 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.293 1.437 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.811 0 CA-C-O 117.013 -1.993 . . . . 0.0 109.701 -179.562 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 p -61.04 4.27 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.981 2.912 . . . . 0.0 115.883 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.5 154.49 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.528 1.058 . . . . 0.0 111.861 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.95 -173.47 44.97 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -145.6 -170.32 3.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 109.522 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -135.27 12.59 3.54 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.372 -0.83 . . . . 0.0 112.153 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.28 82.15 0.16 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -52.03 -50.63 61.04 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.756 1.223 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.79 -27.29 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.307 1.043 . . . . 0.0 112.677 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -77.6 -10.32 59.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.799 -1.188 . . . . 0.0 112.097 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -68.97 143.02 94.02 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 119.802 1.183 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.53 153.8 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.846 1.697 . . . . 0.0 107.731 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.57 -31.52 16.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.096 1.358 . . . . 0.0 113.923 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -69.08 -13.97 62.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.563 1.529 . . . . 0.0 113.476 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -91.27 -12.53 34.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.461 -1.399 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -66.86 127.1 31.21 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -56.64 -34.72 67.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.373 1.469 . . . . 0.0 110.935 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.9 p-90 -84.08 -4.02 58.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.11 1.764 . . . . 0.0 114.437 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -93.14 90.18 6.76 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 109' ' ' SER . 44.0 m-70 -62.61 -63.22 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.463 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.7 84.45 0.59 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 46.66 11.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 pt -43.94 149.65 0.65 Allowed Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 127.302 2.241 . . . . 0.0 114.621 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.95 156.33 47.83 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.61 2.206 . . . . 0.0 111.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -62.18 -21.82 65.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.642 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.774 0.671 . . . . 0.0 110.159 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -79.49 -40.11 30.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.85 0.86 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG21 ' HD3' ' A' ' 41' ' ' ARG . 73.9 t -49.47 -50.01 17.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 C-N-CA 123.924 0.89 . . . . 0.0 110.876 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 -15.03 3.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -96.8 -18.3 19.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.609 0.763 . . . . 0.0 111.669 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 20' ' ' HIS . 45.9 mt -76.49 -47.95 21.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.585 0.629 . . . . 0.0 110.937 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.9 133.91 34.7 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.2 -24.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.033 0.933 . . . . 0.0 110.393 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -124.82 162.6 23.98 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -66.58 117.01 8.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.74 29.63 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 116.857 -2.079 . . . . 0.0 112.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -67.48 131.67 46.12 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 32.3 p90 -142.6 155.14 44.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.58 162.62 40.3 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 126.905 2.082 . . . . 0.0 109.073 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -120.48 123.7 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' HG21 ' A' ' 28' ' ' VAL . 52.5 ptt85 -122.87 135.21 54.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -75.96 144.38 41.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.7 m -68.62 177.32 2.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.647 0.779 . . . . 0.0 110.044 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -31.09 -58.79 0.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.343 2.657 . . . . 0.0 112.265 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.83 -18.34 0.02 OUTLIER Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 24.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 42.71 43.75 3.46 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.929 1.692 . . . . 0.0 114.327 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -115.12 140.42 49.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -105.42 145.74 30.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.123 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.2 t -130.63 115.01 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.027 0.931 . . . . 0.0 109.137 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.7 tp -80.33 102.62 9.67 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -93.92 121.66 35.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.47 160.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 118.614 0.643 . . . . 0.0 109.86 178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.0 tp -112.78 145.76 40.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.543 ' CG ' HG22 ' A' ' 101' ' ' VAL . 56.1 t-105 -145.3 -97.88 0.1 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.89 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -77.25 64.32 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.254 2.622 . . . . 0.0 110.272 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.89 12.34 1.17 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 127.584 2.516 . . . . 0.0 116.223 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -142.14 119.72 7.38 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 119.335 1.568 . . . . 0.0 107.996 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.13 135.0 48.54 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.76 1.64 . . . . 0.0 112.903 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' ' 101' ' ' VAL . 5.3 mmp_? -106.35 119.83 40.28 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.983 2.513 . . . . 0.0 107.167 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -105.73 89.82 3.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.332 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -76.21 108.0 8.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.71 121.05 17.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.92 128.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -100.85 135.65 41.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -111.53 136.08 51.2 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.442 1.497 . . . . 0.0 109.058 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.76 138.88 15.54 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.346 1.458 . . . . 0.0 107.108 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.1 t0 44.41 42.65 5.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.662 1.585 . . . . 0.0 113.186 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.1 t30 66.81 13.98 9.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.788 2.835 . . . . 0.0 113.636 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 77' ' ' GLY . 8.4 mp -121.32 167.55 12.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.571 1.548 . . . . 0.0 108.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.88 134.34 51.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.691 0.796 . . . . 0.0 110.007 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -166.41 151.83 8.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.314 1.046 . . . . 0.0 110.182 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -102.3 -53.14 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -159.43 116.71 2.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.615 1.966 . . . . 0.0 105.766 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.87 17.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.5 171.17 14.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.7 1.75 . . . . 0.0 109.009 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 70' ' ' LEU . . . -132.02 176.04 19.48 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.458 -0.776 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -140.38 155.93 69.87 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.57 -13.06 36.61 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.877 3.051 . . . . 0.0 115.738 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.49 164.44 29.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -69.34 -52.61 14.76 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-O 116.53 -1.7 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.74 -31.2 94.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.509 1.932 . . . . 0.0 113.512 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -43.55 87.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.329 1.451 . . . . 0.0 108.849 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.11 -48.98 16.28 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 109.822 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.1 mm -49.7 -51.5 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.201 0.91 . . . . 0.0 109.302 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.35 -38.81 71.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.514 0.726 . . . . 0.0 111.371 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -61.83 -47.77 83.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.0 -39.91 94.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.58 1.082 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.86 -23.68 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.635 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -95.86 -51.5 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.304 1.442 . . . . 0.0 110.529 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.9 p -73.0 -20.76 60.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.201 1.4 . . . . 0.0 113.829 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 60.42 30.78 20.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.307 1.843 . . . . 0.0 111.765 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -77.48 135.44 65.08 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.293 0.637 . . . . 0.0 110.445 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.04 155.93 52.27 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.036 1.824 . . . . 0.0 108.641 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.85 -50.41 72.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.9 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 p -150.46 144.91 25.7 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -33.47 72.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.276 0.943 . . . . 0.0 108.56 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -56.88 -49.4 75.64 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.768 0.827 . . . . 0.0 109.775 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.8 p -76.99 -32.8 57.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.41 3.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.467 1.508 . . . . 0.0 114.348 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 55' ' ' TRP . 76.6 t -67.86 149.22 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.233 1.813 . . . . 0.0 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -139.3 171.87 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.413 2.285 . . . . 0.0 107.93 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.67 133.37 49.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.732 1.613 . . . . 0.0 107.854 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -129.17 -34.44 1.88 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 123.842 0.714 . . . . 0.0 111.09 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -157.6 146.14 19.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.201 0.909 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -93.77 166.14 12.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.89 124.79 27.71 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.98 159.49 37.74 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.191 1.927 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 20.3 p -76.13 -25.98 55.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.256 1.422 . . . . 0.0 114.481 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.19 -168.11 22.59 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.107 0.384 . . . . 0.0 112.174 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.4 15.89 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.742 3.628 . . . . 0.0 114.222 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.4 t -127.72 81.04 2.0 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.12 1.368 . . . . 0.0 108.314 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 t -91.76 116.33 28.81 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.865 -179.795 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 m -169.98 162.14 9.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.612 1.965 . . . . 0.0 107.764 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.6 m -104.67 -90.59 0.39 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.133 0.973 . . . . 0.0 108.993 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.01 20.37 0.21 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.552 1.072 . . . . 0.0 112.85 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -51.28 104.42 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.547 1.539 . . . . 0.0 113.49 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t -157.94 110.72 2.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.229 1.012 . . . . 0.0 109.615 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.78 65.38 0.76 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.14 1.353 . . . . 0.0 112.579 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.98 -33.61 72.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.755 0.778 . . . . 0.0 110.992 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.88 -23.33 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.29 0.636 . . . . 0.0 111.759 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -83.23 -18.73 38.19 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.258 -0.901 . . . . 0.0 111.92 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -74.0 153.15 88.79 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.597 0.759 . . . . 0.0 111.804 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.52 162.66 40.78 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.133 1.889 . . . . 0.0 108.162 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.98 -34.74 68.39 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 112.828 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.63 1.17 5.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -119.52 10.5 11.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 109.692 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -91.32 133.78 35.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.437 -0.79 . . . . 0.0 111.065 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.02 -25.13 60.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.325 1.85 . . . . 0.0 113.041 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 6.9 p-90 -92.94 -6.47 48.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 113.131 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -91.83 90.05 7.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.9 1.227 . . . . 0.0 111.437 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -77.54 -1.89 32.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -163.05 31.48 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.982 1.719 . . . . 0.0 109.743 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 18.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 pt -40.87 141.6 0.93 Allowed Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.65 154.87 44.58 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.485 2.123 . . . . 0.0 110.811 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.626 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -52.6 -27.76 18.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.525 1.53 . . . . 0.0 114.088 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.41 73.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.708 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.25 -52.68 11.63 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 32' ' ' LEU . 62.1 t -42.94 -51.17 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.332 2.253 . . . . 0.0 112.173 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.9 32.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -94.9 -11.78 28.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.629 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.12 -47.52 24.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 120.32 1.418 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -78.59 138.35 38.32 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.19 -29.27 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.047 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -125.59 152.89 44.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.992 0.901 . . . . 0.0 110.438 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -63.55 121.35 13.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.57 -16.34 19.25 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.496 -1.169 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.3 137.74 53.26 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -139.64 160.83 38.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.338 1.055 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 166.35 33.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.96 2.504 . . . . 0.0 107.201 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.18 138.51 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -140.18 149.77 43.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -81.11 159.23 24.76 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -64.87 164.6 12.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.966 -1.084 . . . . 0.0 109.889 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.3 -20.52 64.41 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.658 -0.652 . . . . 0.0 111.623 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.84 17.83 0.2 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.563 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -132.65 144.57 50.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.869 1.834 . . . . 0.0 106.298 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -73.37 36.26 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.208 1.803 . . . . 0.0 111.947 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -118.98 117.02 27.68 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.157 -1.589 . . . . 0.0 110.185 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -68.33 156.75 37.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.431 1.092 . . . . 0.0 111.588 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.71 121.83 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.156 1.783 . . . . 0.0 109.625 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.4 tp -83.56 134.61 34.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.4 t -126.01 127.62 46.18 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -139.03 160.61 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -112.39 142.06 45.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -150.42 -36.36 0.15 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -145.0 69.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.53 7.15 1.92 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.771 2.129 . . . . 0.0 116.336 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -134.71 121.18 14.81 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.154 2.182 . . . . 0.0 110.273 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.9 112.04 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -83.81 137.89 33.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.26 1.424 . . . . 0.0 108.154 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -118.36 100.73 7.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.34 99.03 11.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.731 1.612 . . . . 0.0 108.615 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.9 mt -63.16 121.41 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.13 118.97 14.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -86.2 154.03 21.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 t -141.01 127.88 20.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.149 2.18 . . . . 0.0 105.808 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.77 -89.76 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.13 52.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.423 2.289 . . . . 0.0 110.733 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.97 -3.92 0.54 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.977 1.711 . . . . 0.0 112.627 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.76 135.71 48.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.706 -1.246 . . . . 0.0 108.816 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.9 127.61 35.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -152.23 168.36 25.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.124 0.57 . . . . 0.0 110.543 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 72' ' ' ARG . 3.6 mm? -139.51 91.81 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.469 1.908 . . . . 0.0 106.746 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.01 -6.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.9 -142.23 5.57 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 120.611 1.55 . . . . 0.0 112.106 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -73.63 159.52 32.95 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.735 1.214 . . . . 0.0 109.208 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.74 178.26 17.11 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-O 121.494 0.496 . . . . 0.0 112.699 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -141.27 158.19 64.63 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.978 0.911 . . . . 0.0 109.817 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -8.87 24.06 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.047 2.498 . . . . 0.0 113.602 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.41 ' HB2' HD23 ' A' ' 83' ' ' LEU . 1.8 m -145.55 162.29 37.77 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.425 1.011 . . . . 0.0 111.152 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mm -68.34 -53.3 18.41 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.09 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.13 -28.02 84.96 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 121.911 1.74 . . . . 0.0 113.976 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.9 mm? -61.14 -48.5 81.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.312 1.445 . . . . 0.0 108.292 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.47 -56.92 8.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.513 1.925 . . . . 0.0 109.317 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.3 mm -48.17 -49.21 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.364 0.984 . . . . 0.0 110.88 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -36.54 80.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.21 0.604 . . . . 0.0 111.223 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.81 -43.25 99.29 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.722 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.92 -42.5 73.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.12 0.568 . . . . 0.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.54 -32.81 71.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.363 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 t -79.85 -55.31 5.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.793 0.837 . . . . 0.0 110.55 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -29.13 68.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 66.4 21.12 10.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.169 1.788 . . . . 0.0 110.958 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.66 147.67 94.66 Favored Pre-proline 0 C--O 1.238 0.449 0 O-C-N 121.564 -0.71 . . . . 0.0 110.53 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.73 133.21 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.295 1.33 . . . . 0.0 108.918 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.39 -48.42 18.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.643 2.377 . . . . 0.0 112.362 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.0 p -151.98 147.54 26.66 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.732 1.213 . . . . 0.0 108.992 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.67 -45.45 92.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -51.86 -27.42 12.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.95 -19.0 6.25 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.54 1.518 . . . . 0.0 112.304 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.23 22.97 31.62 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.093 1.33 . . . . 0.0 114.606 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 53' ' ' VAL . 48.3 t -76.07 142.16 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.777 1.289 . . . . 0.0 111.779 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.06 148.02 31.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.326 1.45 . . . . 0.0 108.838 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.6 124.33 33.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -112.61 -39.19 4.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.103 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.1 ttm105 -163.06 147.59 11.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.579 1.081 . . . . 0.0 110.799 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -80.6 165.13 22.35 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.657 0.783 . . . . 0.0 109.121 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.23 111.61 50.01 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.66 145.12 40.95 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.145 2.563 . . . . 0.0 112.091 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 p -79.25 -25.25 42.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.447 0.699 . . . . 0.0 112.119 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.81 169.32 12.74 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.612 1.577 . . . . 0.0 109.967 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.43 10.45 3.26 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.595 2.863 . . . . 0.0 113.559 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 -20.23 63.16 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.817 -1.177 . . . . 0.0 111.942 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -140.97 73.49 1.42 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -132.43 64.62 1.6 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 117.616 0.708 . . . . 0.0 109.93 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t -75.53 96.74 3.56 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 102.597 -3.112 . . . . 0.0 102.597 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.57 72.03 0.36 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -140.19 154.16 46.84 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.899 1.68 . . . . 0.0 107.352 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 p -120.35 -173.74 2.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.85 61.11 4.85 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.885 1.707 . . . . 0.0 111.8 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.62 -31.47 66.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.448 0.699 . . . . 0.0 111.727 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.51 -34.93 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.873 1.269 . . . . 0.0 111.146 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -76.58 -13.21 60.09 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 111.803 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -71.41 143.76 88.3 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.22 162.31 30.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.271 1.314 . . . . 0.0 109.072 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -52.94 -37.47 61.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.746 0.818 . . . . 0.0 111.43 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -72.86 9.88 1.03 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -124.75 -8.54 7.31 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 109.441 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -70.83 162.5 29.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.414 1.486 . . . . 0.0 112.276 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -78.78 -42.46 27.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.395 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.427 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 13.2 p-90 -73.51 -9.14 58.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.833 2.053 . . . . 0.0 115.604 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 13' ' ' LEU . 65.0 t80 -92.71 100.61 13.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.489 1.04 . . . . 0.0 108.926 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -73.12 -39.96 65.31 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.234 -0.186 . . . . 0.0 110.755 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.78 121.19 1.58 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 35.49 17.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 131.105 3.762 . . . . 0.0 119.898 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.04 147.87 95.96 Favored Pre-proline 0 C--O 1.239 0.515 0 O-C-N 120.067 -1.645 . . . . 0.0 110.882 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 161.13 26.7 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.356 2.037 . . . . 0.0 108.551 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.73 -23.21 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.762 -1.211 . . . . 0.0 113.252 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.25 96.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.317 0.962 . . . . 0.0 109.082 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.8 -33.0 70.27 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 32' ' ' LEU . 70.5 t -56.29 -52.34 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.868 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 -21.83 47.93 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.084 0.856 . . . . 0.0 112.843 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -85.8 -28.16 24.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.531 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.65 -45.35 62.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.432 1.493 . . . . 0.0 113.253 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 28' ' ' VAL . 4.2 mp -76.17 145.0 40.2 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.403 0.547 . . . . 0.0 110.111 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.7 -29.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -122.54 155.08 36.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.31 1.414 . . . . 0.0 111.278 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.67 139.88 56.88 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.41 -4.88 84.98 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 118.281 -1.289 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -70.99 130.5 41.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 53' ' ' VAL . 14.6 p90 -133.94 155.63 49.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 112.181 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.439 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -153.56 165.57 35.48 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.82 1.648 . . . . 0.0 108.223 179.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.8 t -128.42 135.91 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.745 1.218 . . . . 0.0 107.988 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptt85 -128.61 155.82 44.36 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.03 147.55 24.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 168.58 7.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.921 0.867 . . . . 0.0 111.624 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.07 92.87 6.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.998 0.919 . . . . 0.0 108.581 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.11 85.28 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.654 1.597 . . . . 0.0 114.34 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.1 156.59 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.363 1.581 . . . . 0.0 108.853 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.75 40.55 1.13 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.99 103.48 13.32 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.12 156.72 38.8 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.47 122.51 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.839 0.856 . . . . 0.0 108.693 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -84.47 133.85 34.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -132.62 123.63 26.77 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -126.9 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.09 135.78 53.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.174 1.352 . . . . 0.0 108.358 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -157.96 140.17 14.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 54.11 25.06 5.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.85 1.26 . . . . 0.0 112.796 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.74 77.11 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.281 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.58 126.69 19.22 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 120.227 2.013 . . . . 0.0 109.018 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.68 110.35 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.501 2.134 . . . . 0.0 108.089 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -85.0 122.16 28.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.483 1.913 . . . . 0.0 109.407 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -99.08 129.74 45.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.68 96.5 4.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -58.47 118.35 2.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 146.88 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -126.45 116.77 21.66 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.147 0.975 . . . . 0.0 110.224 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.93 107.76 16.12 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 126.231 1.812 . . . . 0.0 107.492 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -130.48 -61.82 0.95 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.244 0.475 . . . . 0.0 111.419 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.77 43.75 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.756 0.822 . . . . 0.0 109.606 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 61.48 -1.03 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 129.806 3.242 . . . . 0.0 113.293 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.73 145.36 43.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.532 2.333 . . . . 0.0 107.924 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 88.1 m-85 -91.68 122.12 33.95 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.893 0.877 . . . . 0.0 108.86 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -140.9 177.05 8.31 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.934 1.294 . . . . 0.0 109.335 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.03 -53.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -141.12 -39.71 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.343 0.657 . . . . 0.0 112.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.93 -148.8 24.29 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.684 1.611 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.59 158.54 17.92 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.009 0.905 . . . . 0.0 109.785 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.87 173.33 14.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 127.443 2.449 . . . . 0.0 108.663 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -138.01 159.57 67.9 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.292 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.86 -13.82 37.08 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.53 2.82 . . . . 0.0 113.805 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 t -145.46 162.12 38.1 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.246 1.018 . . . . 0.0 109.401 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.19 -48.81 75.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.413 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.07 -37.08 44.6 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.951 1.732 . . . . 0.0 112.073 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.09 -33.19 67.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.44 0.696 . . . . 0.0 110.316 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.31 -54.82 5.79 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.154 0.981 . . . . 0.0 109.647 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -44.54 65.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-N 118.917 0.78 . . . . 0.0 111.119 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.56 -27.98 68.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.714 0.688 . . . . 0.0 111.606 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -70.78 -50.61 33.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.3 -33.26 75.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.111 0.414 . . . . 0.0 110.985 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.0 -27.58 69.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.02 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -91.23 -45.81 8.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.088 0.858 . . . . 0.0 110.387 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.7 p -74.15 -19.62 60.5 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.589 -1.319 . . . . 0.0 112.339 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 55.0 26.62 8.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.024 1.73 . . . . 0.0 110.592 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.04 145.91 97.93 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 121.369 -0.832 . . . . 0.0 110.637 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 136.07 31.72 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.985 1.79 . . . . 0.0 109.368 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.7 -35.6 70.85 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.071 1.749 . . . . 0.0 111.466 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -149.57 137.46 20.35 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -59.37 -49.05 79.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.768 -0.582 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -66.57 4.8 0.7 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.08 -27.26 1.25 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.945 1.248 . . . . 0.0 114.329 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.02 12.57 44.04 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 119.833 1.197 . . . . 0.0 115.221 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.26 140.09 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.393 1.477 . . . . 0.0 108.615 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.64 162.67 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.706 1.203 . . . . 0.0 108.322 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.68 118.67 36.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -111.97 -35.63 5.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.882 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -157.43 144.77 18.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.723 1.147 . . . . 0.0 111.996 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -84.18 135.11 34.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.481 1.512 . . . . 0.0 110.445 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.01 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 101.446 -3.538 . . . . 0.0 101.446 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.27 145.07 18.77 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.565 1.51 . . . . 0.0 112.158 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 t -74.58 -30.62 61.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.74 147.91 35.98 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.48 87.14 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.577 3.518 . . . . 0.0 110.591 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -51.69 149.58 4.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.662 1.185 . . . . 0.0 107.821 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.1 m 79.43 11.49 1.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.0 110.65 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 C-N-CA 129.239 3.304 . . . . 0.0 106.946 178.899 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -101.32 117.4 34.9 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.949 2.1 . . . . 0.0 106.404 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -147.83 143.63 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.571 1.148 . . . . 0.0 109.275 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.32 106.42 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -148.24 20.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.267 1.034 . . . . 0.0 111.924 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -71.54 -174.67 1.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.718 0.69 . . . . 0.0 109.938 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 96.02 0.99 Allowed Glycine 0 C--N 1.332 0.312 0 N-CA-C 103.537 -3.825 . . . . 0.0 103.537 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -31.68 51.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.589 0.695 . . . . 0.0 112.638 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.83 -30.85 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 119.389 -0.339 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -72.83 -17.78 61.52 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.528 1.058 . . . . 0.0 111.902 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -77.97 136.89 61.81 Favored Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.62 166.97 22.24 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.07 -35.26 47.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.127 0.571 . . . . 0.0 112.415 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.64 0.02 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.057 1.343 . . . . 0.0 114.424 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -122.48 3.49 9.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.771 1.628 . . . . 0.0 110.696 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -86.14 134.82 33.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.163 0.985 . . . . 0.0 112.149 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -59.61 -23.62 63.12 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.708 2.003 . . . . 0.0 112.028 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -96.62 0.93 50.62 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 114.029 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.8 79.76 4.71 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.945 1.355 . . . . 0.0 107.715 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -64.8 -16.68 63.4 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.892 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -158.48 30.44 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.626 -1.296 . . . . 0.0 112.654 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.11 29.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.985 2.114 . . . . 0.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 pt -58.43 152.85 41.9 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.266 0.939 . . . . 0.0 110.461 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.57 159.93 28.53 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.34 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.8 -23.82 66.46 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.757 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -18.44 65.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.874 1.67 . . . . 0.0 111.924 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -105.36 -34.86 7.71 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.663 1.185 . . . . 0.0 109.654 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.29 -51.12 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 118.921 0.782 . . . . 0.0 111.399 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.48 12.05 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -94.54 -18.55 21.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.856 . . . . 0.0 110.923 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.5 mt -76.95 -50.72 12.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.77 1.228 . . . . 0.0 110.479 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.02 125.84 31.27 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.36 -18.29 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 122.769 0.427 . . . . 0.0 110.821 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -134.24 158.08 44.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.839 -1.163 . . . . 0.0 109.284 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 p -63.5 151.7 40.55 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.274 -0.892 . . . . 0.0 110.978 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.95 -15.45 37.83 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.86 136.27 53.82 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -146.02 162.73 37.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.381 0.672 . . . . 0.0 111.767 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.33 164.13 38.67 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.971 1.708 . . . . 0.0 110.132 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.63 136.41 54.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.9 ptt85 -135.09 157.66 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -92.54 142.23 27.62 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t -64.9 148.27 51.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.127 0.965 . . . . 0.0 108.402 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -65.49 102.82 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.3 5.54 89.52 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.885 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -134.96 141.71 46.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.501 1.651 . . . . 0.0 108.183 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -75.95 11.61 1.37 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.659 1.184 . . . . 0.0 110.743 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.52 112.5 20.04 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.009 -1.057 . . . . 0.0 108.382 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -71.35 165.49 23.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 123.186 1.47 . . . . 0.0 112.587 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.95 135.99 38.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.185 1.794 . . . . 0.0 108.291 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.42 110.23 22.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -109.91 124.65 51.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.71 162.09 38.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.4 tp -111.12 133.73 53.26 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.802 -1.186 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -156.33 146.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 55.73 11.29 0.64 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.135 1.374 . . . . 0.0 113.927 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.95 21.05 59.92 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.898 1.713 . . . . 0.0 110.848 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.457 HD12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -132.15 116.57 15.55 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.764 1.626 . . . . 0.0 110.251 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.17 109.82 2.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.705 2.27 . . . . 0.0 111.513 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -92.28 158.27 16.21 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.263 -1.523 . . . . 0.0 108.286 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -131.29 97.05 4.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.863 0.465 . . . . 0.0 110.915 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.72 102.56 10.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HD21 ' A' ' 73' ' ' LEU . 60.2 mt -59.93 113.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.91 131.57 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -110.83 162.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -130.46 121.26 25.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 128.61 40.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 58.78 24.88 12.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 111.999 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.79 14.78 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.291 2.236 . . . . 0.0 111.686 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.64 134.83 53.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.88 128.44 34.04 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.19 175.93 13.21 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.947 0.899 . . . . 0.0 110.775 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -144.58 -33.14 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 0.0 113.506 177.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -150.8 -61.06 0.19 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.75 -157.2 12.85 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.879 1.228 . . . . 0.0 110.212 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.4 163.73 12.67 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.503 0.721 . . . . 0.0 109.598 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.74 178.09 16.4 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -140.67 160.47 58.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.459 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.34 -10.48 27.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.241 2.627 . . . . 0.0 113.865 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.19 161.94 40.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.921 0.782 . . . . 0.0 109.984 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.9 mm -65.13 -48.87 69.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 117.165 -1.398 . . . . 0.0 110.693 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.23 -33.34 90.33 Favored 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 122.191 1.818 . . . . 0.0 112.244 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.73 -47.69 82.5 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.37 1.068 . . . . 0.0 108.562 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.87 -45.62 74.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.634 -0.666 . . . . 0.0 109.831 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -49.7 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.8 -35.85 66.76 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.864 0.866 . . . . 0.0 111.578 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -72.4 -44.84 61.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.158 0.583 . . . . 0.0 110.829 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.6 -45.22 95.05 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.14 -0.975 . . . . 0.0 110.172 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.35 -34.87 78.66 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 t -73.04 -57.4 4.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.279 0.945 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -64.41 -23.45 67.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.076 1.351 . . . . 0.0 114.454 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 57.69 28.62 16.05 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.709 1.204 . . . . 0.0 109.693 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.69 140.75 84.29 Favored Pre-proline 0 C--O 1.233 0.197 0 O-C-N 121.138 -0.977 . . . . 0.0 110.516 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.78 142.55 22.78 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 95' ' ' LEU . 2.4 mm? -55.05 -49.09 72.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.92 146.3 23.96 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.896 1.279 . . . . 0.0 107.924 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -57.18 -43.89 83.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.466 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -44.65 -76.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.69 1.196 . . . . 0.0 112.714 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -73.0 -27.87 62.04 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.569 0.747 . . . . 0.0 110.845 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.01 70.17 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.025 -1.047 . . . . 0.0 113.347 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -80.67 157.18 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.054 1.342 . . . . 0.0 109.4 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.43 171.2 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.202 1.801 . . . . 0.0 107.975 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.3 mp -114.96 133.57 55.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.833 1.653 . . . . 0.0 106.738 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -118.02 -37.66 3.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.082 0.953 . . . . 0.0 110.617 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -155.23 140.26 17.38 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.489 1.495 . . . . 0.0 110.951 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.61 36.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.843 1.257 . . . . 0.0 107.863 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.99 127.36 67.3 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.32 142.64 9.67 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.216 1.944 . . . . 0.0 110.082 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.0 p -75.85 -38.02 58.42 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.135 -0.978 . . . . 0.0 110.042 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.12 -179.38 31.12 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.588 1.09 . . . . 0.0 112.316 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -80.49 44.51 1.75 Allowed 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.064 4.509 . . . . 0.0 112.795 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -97.71 153.38 18.28 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.827 -1.17 . . . . 0.0 113.078 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.2 m -150.87 152.06 33.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.013 2.125 . . . . 0.0 106.971 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.104 -1.387 . . . . 0.0 110.634 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.187 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -116.72 -83.65 0.63 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -70.86 -5.48 30.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.932 1.242 . . . . 0.0 112.289 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.34 3.01 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.932 1.729 . . . . 0.0 111.088 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p 47.39 64.65 1.51 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.215 2.206 . . . . 0.0 109.776 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 p -156.23 159.36 38.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 120.534 0.207 . . . . 0.0 110.495 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.31 39.16 27.85 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.83 1.681 . . . . 0.0 114.694 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -48.49 -40.4 26.42 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.649 1.224 . . . . 0.0 113.024 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -28.77 18.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.32 -23.7 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.444 0.565 . . . . 0.0 110.114 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.17 146.84 82.42 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 123.503 0.721 . . . . 0.0 112.217 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.26 154.18 56.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.885 2.39 . . . . 0.0 108.353 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.87 -37.81 71.84 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.306 -0.871 . . . . 0.0 111.379 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -64.37 -5.77 5.84 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -112.21 -3.46 14.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.475 1.11 . . . . 0.0 111.078 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -75.48 137.97 41.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.022 0.529 . . . . 0.0 111.804 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.08 -34.46 66.0 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.575 1.55 . . . . 0.0 111.887 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -82.56 -2.32 53.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 114.014 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.53 88.92 7.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -83.2 -9.93 58.88 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.07 -170.38 33.07 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.005 1.275 . . . . 0.0 111.6 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.99 27.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.289 1.836 . . . . 0.0 114.988 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 pt -55.56 138.76 68.78 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 124.256 1.022 . . . . 0.0 111.787 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -74.63 172.69 15.7 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.569 1.513 . . . . 0.0 109.339 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -68.24 -17.2 64.24 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.97 67.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.96 0.8 . . . . 0.0 109.967 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -84.19 -34.71 23.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.946 0.898 . . . . 0.0 111.179 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.3 t -53.67 -46.83 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 118.836 0.744 . . . . 0.0 109.542 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -18.6 12.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.63 -12.03 19.53 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 113.444 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.83 -44.55 22.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.964 0.906 . . . . 0.0 108.787 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.51 144.89 41.76 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.83 -30.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 123.683 0.793 . . . . 0.0 112.201 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.99 171.2 14.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.943 0.878 . . . . 0.0 111.918 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.3 126.82 29.21 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.056 0.942 . . . . 0.0 108.948 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.2 -8.51 64.85 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.037 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.41 144.19 53.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -150.65 162.34 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.372 0.669 . . . . 0.0 112.232 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.51 170.98 21.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.053 2.141 . . . . 0.0 109.19 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -119.37 132.83 68.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HD3' HG21 ' A' ' 28' ' ' VAL . 53.4 ptt85 -132.76 128.81 37.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -74.54 152.83 39.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t -64.72 159.97 21.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -70.23 26.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.29 -70.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.592 0 O-C-N 120.372 -1.455 . . . . 0.0 110.283 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -59.9 141.2 55.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -71.73 86.13 0.93 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.809 0.844 . . . . 0.0 108.825 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -147.9 131.8 17.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -102.61 136.71 41.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.01 117.49 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.718 1.207 . . . . 0.0 108.814 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 tp -78.48 116.17 18.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.01 119.05 38.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.12 169.75 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 tp -119.34 136.17 54.38 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 120.421 1.464 . . . . 0.0 107.382 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -162.94 138.41 6.84 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.74 43.14 31.46 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.384 1.088 . . . . 0.0 109.581 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.44 30.2 55.05 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 126.014 1.769 . . . . 0.0 114.392 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 tt -144.68 119.24 5.8 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.759 1.28 . . . . 0.0 109.211 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.15 117.21 4.63 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.573 2.849 . . . . 0.0 111.053 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -91.89 119.02 31.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.888 2.075 . . . . 0.0 111.59 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' HH21 ' A' ' 41' ' ' ARG . 72.4 m-70 -98.37 121.2 40.01 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 95' ' ' LEU . 91.2 m-85 -109.78 115.55 30.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.54 108.02 2.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.85 102.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.45 164.09 17.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 p -136.71 112.56 9.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 68' ' ' ASP . 4.8 tt -148.73 138.42 22.03 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.016 1.326 . . . . 0.0 110.91 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 m120 64.23 17.64 10.82 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 126.644 1.978 . . . . 0.0 112.199 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -122.56 159.45 27.73 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.26 1.424 . . . . 0.0 107.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -108.22 126.63 53.02 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.407 HH21 HD13 ' A' ' 67' ' ' LEU . 36.5 ptt180 -151.19 162.99 39.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.532 1.933 . . . . 0.0 110.086 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.32 -44.33 1.02 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.752 0.706 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.32 -50.8 0.52 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.49 -156.12 18.7 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.93 173.49 5.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.404 1.482 . . . . 0.0 109.562 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.4 175.57 15.76 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.818 -0.551 . . . . 0.0 112.171 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -142.23 158.12 61.9 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.145 -0.527 . . . . 0.0 111.892 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.33 -6.19 15.73 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.618 3.545 . . . . 0.0 114.156 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' HD23 ' A' ' 83' ' ' LEU . 1.1 t -153.08 162.24 41.55 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -66.57 -48.01 55.81 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 116.515 -1.707 . . . . 0.0 110.582 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.88 -34.6 90.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.723 2.008 . . . . 0.0 112.476 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.0 mm? -59.33 -38.87 81.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.377 0.671 . . . . 0.0 109.633 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.97 -52.1 9.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.251 1.02 . . . . 0.0 109.781 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.22 -47.97 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.711 0.687 . . . . 0.0 109.407 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.85 -40.22 75.72 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -60.08 -49.76 76.38 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 118.377 -0.821 . . . . 0.0 110.185 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.38 -41.2 98.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.282 0.946 . . . . 0.0 111.213 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.68 -36.1 81.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 t -71.07 -52.81 17.29 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.424 1.89 . . . . 0.0 110.55 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -79.12 -23.42 44.05 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.41 31.39 20.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.205 1.002 . . . . 0.0 109.392 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -74.22 150.45 87.55 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.161 0.984 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.67 131.94 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 N-CA-C 107.156 -1.901 . . . . 0.0 107.156 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 62' ' ' PHE . 2.4 mt -45.38 -42.42 10.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.468 2.307 . . . . 0.0 112.7 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 160.53 42.73 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -60.1 -59.94 4.62 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 119.003 -0.522 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -54.68 -74.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.945 0.898 . . . . 0.0 111.043 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 p -80.71 101.82 9.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.33 45.08 1.17 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.477 1.036 . . . . 0.0 113.588 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.16 142.97 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.861 1.664 . . . . 0.0 107.863 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.82 143.14 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 95' ' ' LEU . 10.3 mp -84.33 111.79 19.74 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -87.52 -48.13 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -163.5 154.2 16.11 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.39 147.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.168 1.387 . . . . 0.0 109.723 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.66 105.32 43.79 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.85 157.24 62.37 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 CA-C-N 121.829 1.689 . . . . 0.0 111.058 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -70.74 -69.37 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.88 28.14 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.372 1.939 . . . . 0.0 111.781 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.49 -176.66 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.327 2.684 . . . . 0.0 111.482 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -55.75 171.96 0.2 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.765 1.626 . . . . 0.0 111.451 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.3 p -62.69 151.94 36.86 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.146 -0.971 . . . . 0.0 109.78 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 117.222 -1.877 . . . . 0.0 109.33 -179.431 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.36 168.07 20.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.814 0.846 . . . . 0.0 111.491 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -166.1 174.8 8.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 130.439 3.496 . . . . 0.0 105.159 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 50.65 0.03 OUTLIER Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 113.747 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.68 167.19 21.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.209 1.504 . . . . 0.0 108.532 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.8 m -130.35 91.72 3.15 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.783 1.233 . . . . 0.0 107.692 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 41.05 68.14 0.67 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 126.375 1.94 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -49.61 -46.94 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.538 1.535 . . . . 0.0 111.474 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.5 -14.07 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.078 0.951 . . . . 0.0 112.533 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -92.14 -18.8 23.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.389 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -58.42 147.02 70.15 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.412 1.085 . . . . 0.0 110.584 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.29 167.38 27.47 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.163 1.908 . . . . 0.0 108.388 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.611 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.47 -33.53 72.71 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 112.107 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -7.45 19.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.312 1.045 . . . . 0.0 113.688 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.99 4.12 19.28 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.145 1.778 . . . . 0.0 111.683 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -89.47 141.79 28.25 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.328 -0.857 . . . . 0.0 112.668 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.22 -34.22 73.36 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.816 1.246 . . . . 0.0 111.071 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -80.91 4.88 17.87 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.065 1.346 . . . . 0.0 113.304 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' CE1' HD21 ' A' ' 13' ' ' LEU . 34.3 t80 -91.29 90.16 7.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.557 ' CE1' HD13 ' A' ' 31' ' ' LEU . 74.2 m-70 -84.41 -13.09 53.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.56 -168.93 29.69 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 18.58 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.5 pt -44.47 139.99 3.24 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 126.095 1.758 . . . . 0.0 114.314 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -83.35 167.78 13.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.479 2.786 . . . . 0.0 111.15 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.92 -33.87 57.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.75 74.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.65 0.78 . . . . 0.0 112.914 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -90.68 -31.29 16.66 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 122.867 0.467 . . . . 0.0 110.58 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 51.2 t -58.46 -50.1 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.71 -20.76 2.25 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.27 -26.28 33.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.483 1.038 . . . . 0.0 112.424 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD13 ' CE1' ' A' ' 20' ' ' HIS . 19.2 mt -75.19 -50.26 16.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.906 1.283 . . . . 0.0 109.86 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 28' ' ' VAL . 3.3 mp -78.46 125.68 29.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.24 -27.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.858 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -124.73 159.23 31.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.635 1.174 . . . . 0.0 108.098 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 p -65.73 152.55 44.02 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.141 -0.974 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.75 -10.48 67.53 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.652 -1.082 . . . . 0.0 111.439 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -68.02 138.23 55.7 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -146.15 155.53 42.79 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.999 1.272 . . . . 0.0 112.686 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.38 168.1 28.4 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.631 1.572 . . . . 0.0 111.049 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.3 142.6 36.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -141.02 143.6 34.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 125.109 1.364 . . . . 0.0 110.204 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.08 154.01 41.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -67.07 172.79 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.515 -1.365 . . . . 0.0 108.411 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -66.34 22.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.654 2.781 . . . . 0.0 113.759 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.26 -14.65 1.66 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.331 0.969 . . . . 0.0 112.021 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -98.32 151.4 20.54 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -80.29 16.6 1.24 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.512 0.725 . . . . 0.0 112.226 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -84.59 123.17 30.03 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.417 1.887 . . . . 0.0 108.297 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -79.63 146.62 32.41 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.87 128.51 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.873 1.669 . . . . 0.0 107.448 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.3 144.8 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -141.9 130.54 22.71 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 119.52 -1.988 . . . . 0.0 107.303 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -132.25 169.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.9 tp -117.17 138.99 51.31 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -141.73 -51.45 0.42 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -145.66 79.54 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.41 18.47 10.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.873 1.702 . . . . 0.0 115.632 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.41 114.77 6.25 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.409 1.084 . . . . 0.0 108.96 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.36 91.34 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 N-CA-C 106.055 -2.325 . . . . 0.0 106.055 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -65.61 121.9 16.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.776 2.03 . . . . 0.0 110.371 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -99.38 131.51 45.35 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -124.95 105.58 9.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.082 1.753 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 63' ' ' ILE . 3.8 mp -65.95 125.55 23.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.18 128.7 37.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -108.03 148.14 30.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 t -134.21 133.91 41.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 tp -136.89 -68.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.84 34.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.414 0.686 . . . . 0.0 110.37 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.89 9.67 7.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.589 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.34 139.04 50.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.187 2.195 . . . . 0.0 106.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.38 128.78 36.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -153.41 157.7 40.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.989 0.516 . . . . 0.0 111.422 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.37 -21.39 4.95 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.776 1.63 . . . . 0.0 113.163 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.95 -14.95 0.71 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.57 -74.54 0.1 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.01 1.277 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.84 144.43 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.47 -177.75 18.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.888 1.232 . . . . 0.0 110.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -145.85 157.59 50.64 Favored Pre-proline 0 N--CA 1.465 0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.527 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.98 -14.37 44.88 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 124.638 3.559 . . . . 0.0 114.74 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' HD23 ' A' ' 83' ' ' LEU . 4.1 m -135.33 157.03 47.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.41 0.684 . . . . 0.0 109.517 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 mm -68.67 -52.34 19.05 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.844 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.69 -32.04 86.56 Favored 'Trans proline' 0 C--N 1.355 0.877 0 CA-C-N 121.575 1.598 . . . . 0.0 111.579 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 80' ' ' SER . 1.7 mm? -58.09 -48.74 79.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.192 0.997 . . . . 0.0 108.474 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -51.69 48.7 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.911 0.884 . . . . 0.0 109.421 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.73 -50.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.191 0.905 . . . . 0.0 109.424 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.38 -35.98 65.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.908 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -43.14 74.19 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.464 1.029 . . . . 0.0 110.687 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.04 -39.99 87.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 110.31 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.85 -28.39 66.68 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.603 0.761 . . . . 0.0 110.519 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -77.15 -59.87 2.6 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.38 1.872 . . . . 0.0 108.913 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -67.99 -22.76 64.99 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.539 1.135 . . . . 0.0 113.645 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 55.8 35.86 26.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.192 0.997 . . . . 0.0 109.412 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -80.82 160.8 65.66 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 126.011 1.725 . . . . 0.0 110.951 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.62 136.32 8.44 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.166 1.244 . . . . 0.0 109.93 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -50.38 -49.06 55.45 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.802 2.041 . . . . 0.0 111.083 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p -149.4 148.84 29.95 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -63.63 -48.75 76.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.155 0.582 . . . . 0.0 109.557 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.65 -14.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.862 2.065 . . . . 0.0 116.091 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 p -132.59 -8.86 3.22 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.182 1.81 . . . . 0.0 113.772 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.19 7.35 5.1 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 53' ' ' VAL . 21.0 t -68.8 140.86 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 126.173 1.789 . . . . 0.0 109.931 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.45 152.1 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.624 2.369 . . . . 0.0 105.651 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.05 127.97 38.77 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -116.39 -31.78 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.996 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.74 139.51 5.36 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.99 162.16 27.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.95 137.17 28.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.23 156.27 8.21 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.228 2.619 . . . . 0.0 113.132 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 12.6 t -67.12 -31.6 72.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.202 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.25 -116.56 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.84 173.34 14.6 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.084 2.523 . . . . 0.0 110.287 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -164.95 149.82 9.34 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.701 0.8 . . . . 0.0 109.589 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.3 m -167.3 -175.61 2.98 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 130.279 3.431 . . . . 0.0 106.655 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -148.52 82.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.71 -47.83 83.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.783 0.833 . . . . 0.0 111.134 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.54 179.69 53.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -131.52 141.16 49.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.1 m -151.6 128.33 10.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.036 2.134 . . . . 0.0 106.513 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.94 103.71 1.26 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -45.63 -43.0 12.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 110.499 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.75 -26.65 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.134 1.374 . . . . 0.0 114.126 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -17.11 61.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.317 0.962 . . . . 0.0 111.884 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -60.57 147.83 82.5 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 121.594 -0.691 . . . . 0.0 109.535 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.97 155.69 59.05 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.461 1.441 . . . . 0.0 109.243 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.513 HD21 ' CE1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -58.75 -32.38 69.2 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 16.6 p80 -69.08 -9.81 54.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -99.09 -10.42 22.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.707 1.14 . . . . 0.0 111.647 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.29 140.25 58.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.783 1.233 . . . . 0.0 111.512 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -64.76 -33.88 77.01 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.35 0.66 . . . . 0.0 110.882 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -81.87 -3.74 54.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.712 1.605 . . . . 0.0 113.526 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' HD21 ' A' ' 13' ' ' LEU . 45.6 t80 -89.01 84.67 6.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.8 -10.86 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.49 -161.23 20.5 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 54.81 3.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.472 1.509 . . . . 0.0 109.564 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 pt -82.06 150.57 65.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.866 -0.521 . . . . 0.0 112.161 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.76 156.66 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.211 1.941 . . . . 0.0 109.536 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -62.38 -23.79 67.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.098 -0.954 . . . . 0.0 112.09 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.93 72.46 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.732 0.645 . . . . 0.0 110.271 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -73.8 -52.02 14.48 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG13 HD21 ' A' ' 39' ' ' LEU . 48.9 t -47.57 -48.12 10.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.06 -21.29 8.05 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -99.76 -7.18 25.84 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.053 . . . . 0.0 112.146 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.97 -44.81 37.98 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.028 0.931 . . . . 0.0 110.29 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.82 110.95 18.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.18 -38.07 7.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.531 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -133.18 170.75 14.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 p -62.83 122.19 15.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.597 1.159 . . . . 0.0 110.217 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.07 -13.15 31.58 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 119.938 1.245 . . . . 0.0 111.164 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -79.9 128.2 33.17 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 17.2 p90 -136.03 159.32 42.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.146 1.378 . . . . 0.0 110.855 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -157.13 174.99 14.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.932 1.693 . . . . 0.0 107.477 177.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.77 146.86 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' CD ' HG21 ' A' ' 28' ' ' VAL . 33.1 ptt85 -138.81 142.53 38.7 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -80.99 147.48 30.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -76.47 65.49 2.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.558 1.143 . . . . 0.0 107.927 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -20.6 101.88 0.02 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 129.332 3.053 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.02 5.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.239 1.876 . . . . 0.0 111.405 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.68 155.74 44.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.349 1.575 . . . . 0.0 110.249 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.53 ' NE2' ' H ' ' A' ' 47' ' ' GLN 0.256 0.4 OUTLIER -80.02 85.62 5.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.656 1.182 . . . . 0.0 109.473 179.56 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -151.37 142.01 22.7 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 128.073 2.549 . . . . 0.0 105.321 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -110.49 151.15 27.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.256 1.027 . . . . 0.0 109.884 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.8 t -132.44 115.63 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 108.085 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.1 tp -81.81 101.97 10.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 121.03 32.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -136.91 151.95 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 119.935 1.243 . . . . 0.0 109.295 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.68 142.65 35.98 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.709 0.804 . . . . 0.0 108.946 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 101' ' ' VAL . 55.3 t-105 -142.1 -60.61 0.46 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 81.91 2.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.013 0.525 . . . . 0.0 110.893 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.33 11.36 1.09 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -145.28 117.61 5.27 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.364 1.466 . . . . 0.0 107.256 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.31 94.45 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.247 2.631 . . . . 0.0 109.183 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -58.78 143.94 45.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 108.502 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.26 104.64 11.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -96.62 109.88 22.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.7 mt -69.15 114.31 5.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.79 122.81 12.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -93.6 143.29 26.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.811 1.644 . . . . 0.0 108.181 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 118.84 9.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.64 -76.25 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -93.81 31.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.164 1.786 . . . . 0.0 109.373 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 79.13 -8.86 1.57 Allowed 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 128.866 2.866 . . . . 0.0 112.629 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.18 123.01 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 81' ' ' ILE . 72.8 m-85 -83.16 135.89 34.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.317 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.51 172.45 10.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.301 1.84 . . . . 0.0 109.632 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.91 -26.53 1.18 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.63 1.172 . . . . 0.0 111.52 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -129.06 -46.44 1.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.178 1.354 . . . . 0.0 112.286 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.53 -123.57 2.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 119.88 1.218 . . . . 0.0 112.966 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -48.38 144.12 4.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.493 1.517 . . . . 0.0 111.753 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 169.41 15.97 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.46 156.21 80.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 123.697 0.799 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.28 -5.11 10.52 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.966 3.11 . . . . 0.0 113.991 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.454 ' HB2' HD23 ' A' ' 83' ' ' LEU . 15.6 m -148.1 158.12 43.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.416 -0.803 . . . . 0.0 111.788 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 71' ' ' TYR . 3.7 mp -66.03 -52.28 41.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.516 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.7 -41.83 66.3 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 121.405 1.537 . . . . 0.0 111.58 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 80' ' ' SER . 3.3 mm? -52.0 -48.93 64.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.407 1.483 . . . . 0.0 110.089 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.45 -48.23 56.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.913 0.885 . . . . 0.0 110.46 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.2 -42.8 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 123.851 0.86 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.88 -39.56 94.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.745 0.702 . . . . 0.0 110.237 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.67 -47.69 84.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.13 -42.53 93.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.816 0.734 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.11 -42.7 99.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.263 0.625 . . . . 0.0 109.723 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -70.71 -40.63 72.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.744 . . . . 0.0 112.415 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.8 p -88.71 -19.42 26.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 63.87 31.05 14.21 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.203 2.201 . . . . 0.0 111.243 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -74.83 148.6 85.04 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.789 0.836 . . . . 0.0 110.554 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.81 149.61 29.75 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.191 1.927 . . . . 0.0 110.435 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.61 -39.82 84.75 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 111.263 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.52 136.67 3.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.915 0.886 . . . . 0.0 110.093 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.4 -33.76 31.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.737 2.015 . . . . 0.0 115.407 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -68.11 -17.32 64.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.463 -1.255 . . . . 0.0 113.493 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -135.4 -5.42 2.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.08 1.309 . . . . 0.0 114.279 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.55 12.01 0.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.74 2.114 . . . . 0.0 118.237 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 53' ' ' VAL . 34.1 t -56.45 134.6 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.132 1.466 . . . . 0.0 113.526 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.69 146.18 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.572 1.149 . . . . 0.0 108.266 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.56 131.11 35.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -115.03 -44.71 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.874 0.469 . . . . 0.0 109.756 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -155.23 145.21 21.62 Favored 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.668 -0.645 . . . . 0.0 110.524 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 155.4 27.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.9 111.39 64.93 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.73 147.83 19.75 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.437 1.425 . . . . 0.0 108.812 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -15.55 59.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.3 0.955 . . . . 0.0 108.956 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.3 -166.64 52.55 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.263 1.411 . . . . 0.0 110.598 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.08 15.74 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.851 3.034 . . . . 0.0 114.162 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.06 12.33 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.675 -1.89 . . . . 0.0 113.19 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t -131.75 8.93 4.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.456 1.103 . . . . 0.0 111.004 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -179.659 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -130.88 87.86 2.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -142.88 -156.72 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.784 1.634 . . . . 0.0 109.561 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -160.72 20.93 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m -68.85 68.27 0.16 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.705 1.602 . . . . 0.0 113.051 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -91.8 107.64 19.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 26.97 71.83 0.03 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 129.0 3.191 . . . . 0.0 117.194 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -54.64 -32.85 59.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.057 0.943 . . . . 0.0 110.491 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.58 -31.26 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.656 1.582 . . . . 0.0 113.002 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -15.03 30.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.362 1.437 . . . . 0.0 113.376 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -58.58 135.62 86.05 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.26 153.9 71.3 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.3 tt -51.56 -37.6 50.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.2 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -71.25 -0.56 10.22 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.12 7.23 11.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.522 1.929 . . . . 0.0 109.286 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -80.61 143.71 32.93 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -68.82 -11.99 61.04 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.883 1.273 . . . . 0.0 112.494 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -105.41 1.14 27.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.739 1.616 . . . . 0.0 112.395 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 13' ' ' LEU . 49.2 t80 -87.33 91.71 8.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -77.46 -12.94 60.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.77 -160.42 23.34 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 15.21 0.31 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 pt -38.46 134.79 0.94 Allowed Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.0 157.03 61.25 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.87 1.713 . . . . 0.0 109.999 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -55.22 -21.63 14.76 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.64 -33.57 66.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.297 0.953 . . . . 0.0 110.671 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.56 -39.4 58.22 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 HG21 ' HD3' ' A' ' 41' ' ' ARG . 74.2 t -55.91 -44.52 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.647 0.779 . . . . 0.0 109.757 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.16 41.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.25 -23.2 24.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 120.183 1.356 . . . . 0.0 112.651 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.18 -52.68 63.82 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.499 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -83.73 110.58 18.43 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 m -104.22 -31.76 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 118.166 -0.921 . . . . 0.0 113.372 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -130.64 159.99 35.56 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.455 1.025 . . . . 0.0 111.429 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -56.31 138.59 50.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.739 -0.601 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.06 -5.66 84.54 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.568 1.556 . . . . 0.0 113.499 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.61 129.19 38.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HB2' HG12 ' A' ' 53' ' ' VAL . 25.2 p90 -134.35 160.54 37.6 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.599 1.09 . . . . 0.0 113.666 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.78 166.8 23.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.274 2.23 . . . . 0.0 109.335 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.88 142.79 39.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.15 0.98 . . . . 0.0 108.483 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HD3' HG21 ' A' ' 28' ' ' VAL . 22.8 ptt85 -135.67 161.69 34.84 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -109.49 138.09 46.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.77 102.03 11.86 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -3.77 -90.75 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 130.205 3.402 . . . . 0.0 116.385 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.76 86.03 Favored Glycine 0 C--N 1.338 0.693 0 O-C-N 121.026 -1.046 . . . . 0.0 115.592 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -88.75 -15.89 33.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.582 -1.675 . . . . 0.0 109.562 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 44.2 28.13 0.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.245 2.218 . . . . 0.0 112.08 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.86 141.73 47.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.389 1.475 . . . . 0.0 109.676 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -84.94 148.88 25.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.499 1.119 . . . . 0.0 108.544 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.55 118.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.173 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -84.58 98.0 9.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.6 t -92.18 122.64 34.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -131.24 142.94 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.4 143.37 27.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.432 ' CB ' HG22 ' A' ' 101' ' ' VAL . 19.2 t-105 -155.66 129.56 8.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 55.64 37.15 28.5 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.702 1.201 . . . . 0.0 109.461 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.35 78.09 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.925 -1.486 . . . . 0.0 114.238 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.5 125.79 20.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 120.684 2.242 . . . . 0.0 109.262 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.18 100.82 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.598 2.199 . . . . 0.0 111.268 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -80.18 116.0 20.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -94.11 99.75 11.98 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.661 0.784 . . . . 0.0 110.323 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -90.51 102.69 15.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.85 121.66 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.7 134.5 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -109.26 146.47 34.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.012 0.925 . . . . 0.0 109.996 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 1.4 p -137.81 146.45 43.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.332 2.253 . . . . 0.0 107.212 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 tt -160.66 -61.12 0.06 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.761 0.71 . . . . 0.0 110.68 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -97.6 56.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.784 0.833 . . . . 0.0 109.938 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.23 -0.91 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 128.293 2.637 . . . . 0.0 115.754 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.71 157.09 34.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.749 2.019 . . . . 0.0 107.789 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 66' ' ' SER . 44.9 m-85 -101.92 137.15 40.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 156.31 36.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.59 1.086 . . . . 0.0 110.132 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.85 93.97 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.12 18.73 5.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.327 1.851 . . . . 0.0 115.322 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.44 -152.59 6.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.61 168.84 8.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.453 1.101 . . . . 0.0 108.567 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.13 171.73 23.51 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -144.96 159.59 49.49 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.493 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.72 -6.97 18.09 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.75 3.634 . . . . 0.0 113.747 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.439 ' HB2' HD23 ' A' ' 83' ' ' LEU . 24.0 m -144.03 152.11 40.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.32 -49.28 54.62 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.048 -1.453 . . . . 0.0 110.037 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.33 -32.54 96.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 122.67 1.989 . . . . 0.0 114.248 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 80' ' ' SER . 2.2 mm? -56.42 -40.67 75.09 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.533 1.533 . . . . 0.0 109.797 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.69 -46.72 15.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.953 2.101 . . . . 0.0 111.951 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.1 mm -53.45 -39.3 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.173 0.897 . . . . 0.0 109.294 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.18 -48.2 71.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.761 0.824 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -59.1 -48.65 80.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.944 0.898 . . . . 0.0 111.523 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.87 -45.72 93.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.333 0.653 . . . . 0.0 112.308 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.63 -43.86 88.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.7 t -72.45 -9.13 58.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.237 1.815 . . . . 0.0 114.725 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.499 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -127.07 -17.67 4.78 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.561 1.528 . . . . 0.0 112.388 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 61.74 23.71 13.98 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.318 1.847 . . . . 0.0 112.628 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 12.2 pt20 -63.24 144.35 97.47 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.636 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.26 138.76 18.16 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.549 1.499 . . . . 0.0 109.378 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.49 -37.79 76.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.854 1.262 . . . . 0.0 112.253 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -153.99 154.3 33.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 109.212 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -65.13 0.74 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.303 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -48.1 -68.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.755 0.707 . . . . 0.0 110.803 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.27 -47.33 36.28 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 112.69 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.26 14.91 71.96 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 119.958 1.253 . . . . 0.0 114.467 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 55' ' ' TRP . 45.6 t -72.58 143.63 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.294 2.238 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.55 151.33 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.372 1.869 . . . . 0.0 106.926 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.3 104.49 16.84 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -81.56 -46.41 14.49 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -165.48 150.87 9.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.842 1.201 . . . . 0.0 111.852 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.13 143.8 36.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.634 1.974 . . . . 0.0 109.261 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 t -95.88 115.58 65.64 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.71 139.78 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.5 2.133 . . . . 0.0 113.26 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -60.72 2.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.118 0.967 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.8 164.85 38.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.26 120.32 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.732 2.955 . . . . 0.0 111.276 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.57 172.41 4.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.5 p -142.38 169.96 16.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.253 -0.904 . . . . 0.0 110.292 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.843 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -137.6 177.77 7.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 111.355 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 p 39.97 54.81 2.64 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.842 2.457 . . . . 0.0 111.388 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.2 -21.61 60.47 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.428 -1.207 . . . . 0.0 115.258 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t 176.01 -176.07 0.11 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 128.92 2.888 . . . . 0.0 106.053 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 p -134.27 -9.05 2.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.158 1.783 . . . . 0.0 111.957 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.65 95.11 0.43 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -51.54 -34.72 37.76 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.367 1.067 . . . . 0.0 111.159 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.88 -27.06 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.125 1.37 . . . . 0.0 112.709 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -74.13 -23.38 59.28 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.606 1.163 . . . . 0.0 111.791 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -64.15 152.27 88.41 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 118.104 0.411 . . . . 0.0 110.397 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.94 155.51 69.45 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -58.52 -31.02 67.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -64.07 -6.65 6.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -114.37 -6.14 12.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.338 1.427 . . . . 0.0 111.973 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -73.78 136.03 43.57 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.703 -0.623 . . . . 0.0 109.321 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -30.77 66.15 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.74 1.216 . . . . 0.0 112.624 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -82.08 -5.82 58.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 13' ' ' LEU . 33.1 t80 -89.51 89.32 7.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' HD13 ' A' ' 31' ' ' LEU . 29.5 m-70 -71.95 -23.7 61.49 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.175 -0.328 . . . . 0.0 110.901 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.13 101.72 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 42.93 20.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.237 2.615 . . . . 0.0 117.761 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 pt -58.2 151.7 45.73 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 119.567 1.076 . . . . 0.0 112.601 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.56 167.45 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.142 2.561 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -58.5 -27.07 64.13 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.971 -0.456 . . . . 0.0 111.721 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.1 72.19 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.161 2.184 . . . . 0.0 112.144 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.48 -46.36 8.75 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.491 0.587 . . . . 0.0 109.617 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.57 -50.63 2.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.978 1.711 . . . . 0.0 113.228 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.44 63.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.378 0.671 . . . . 0.0 112.8 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.92 -9.89 35.61 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.374 1.069 . . . . 0.0 112.273 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 20' ' ' HIS . 95.1 mt -85.52 -47.91 9.45 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 120.607 -1.308 . . . . 0.0 109.266 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mt -75.54 121.38 22.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.982 0.913 . . . . 0.0 108.617 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.74 -33.53 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.166 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -126.7 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.48 1.036 . . . . 0.0 111.38 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -59.61 136.92 58.14 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.75 -0.594 . . . . 0.0 109.933 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.812 -1.549 . . . . 0.0 112.299 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.51 145.72 55.75 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.79 161.4 40.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 120.677 1.58 . . . . 0.0 112.781 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.7 168.2 27.92 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.913 1.685 . . . . 0.0 110.97 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.79 136.07 60.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.235 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -136.7 170.1 16.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -111.8 154.97 24.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 143.09 47.78 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.43 125.39 23.51 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.35 15.46 38.51 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 116.989 -2.006 . . . . 0.0 115.804 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -145.17 130.16 18.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 121.17 2.485 . . . . 0.0 110.014 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -73.88 92.52 2.08 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.08 114.59 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -76.86 160.67 29.05 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.561 1.172 . . . . 0.0 109.901 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.7 t -138.09 136.31 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.844 1.258 . . . . 0.0 107.787 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.98 103.13 12.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -104.83 123.46 47.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.42 168.14 22.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.08 136.51 52.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -156.69 145.87 20.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 56.65 1.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.988 1.315 . . . . 0.0 113.493 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.6 4.68 46.03 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.107 1.813 . . . . 0.0 112.484 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.89 128.13 25.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.445 1.898 . . . . 0.0 109.841 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.84 99.87 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.353 2.035 . . . . 0.0 110.957 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -75.4 111.06 10.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.7 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -93.03 137.12 32.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -127.8 127.15 43.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.028 1.331 . . . . 0.0 108.896 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.41 125.36 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.4 mt -72.87 104.98 2.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -79.92 159.37 26.38 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.9 p -139.85 130.98 26.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.025 1.33 . . . . 0.0 110.575 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.99 142.56 19.74 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 60.76 19.82 9.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.424 1.489 . . . . 0.0 114.307 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.65 26.27 1.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.453 1.901 . . . . 0.0 109.612 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.8 151.13 50.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.389 1.876 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -107.45 136.92 46.43 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -165.21 174.08 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.863 0.865 . . . . 0.0 111.848 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -134.0 -30.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.876 1.671 . . . . 0.0 109.938 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -156.78 -67.36 0.1 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.293 0.951 . . . . 0.0 109.474 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.83 -177.57 35.94 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -50.06 145.17 6.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.6 0.76 . . . . 0.0 111.169 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.58 -173.47 22.24 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -146.28 164.07 26.75 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.777 0.831 . . . . 0.0 110.621 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.85 -7.91 16.36 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.588 3.525 . . . . 0.0 115.63 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -146.58 161.37 40.64 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.972 1.26 . . . . 0.0 108.694 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.1 mm -63.96 -51.2 65.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.349 -1.31 . . . . 0.0 111.202 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.07 -34.76 45.54 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.827 1.688 . . . . 0.0 112.281 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.28 -45.36 72.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 0.0 109.76 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.06 -46.74 49.97 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.797 0.439 . . . . 0.0 110.645 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 -39.37 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.894 0.77 . . . . 0.0 110.641 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.2 -43.57 82.86 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.702 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -62.53 -45.99 90.44 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.96 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.62 -50.61 73.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.759 1.163 . . . . 0.0 110.225 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.3 -44.62 95.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.8 t -70.49 -8.21 49.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.987 1.715 . . . . 0.0 114.253 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 93' ' ' GLN . 1.2 t -131.41 -15.05 3.25 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.822 1.646 . . . . 0.0 113.75 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 60.3 27.65 17.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.604 1.561 . . . . 0.0 111.801 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 91' ' ' THR . 3.2 pt20 -68.51 144.38 96.29 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 121.487 -0.758 . . . . 0.0 109.88 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.56 136.41 19.26 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.357 1.371 . . . . 0.0 109.134 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.616 1.566 . . . . 0.0 111.483 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -148.79 138.34 21.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.765 1.226 . . . . 0.0 109.322 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -60.97 -45.82 93.22 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.487 1.115 . . . . 0.0 108.701 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -64.26 -12.27 39.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.94 -16.08 5.21 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 121.019 1.736 . . . . 0.0 114.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.82 16.7 7.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.725 1.631 . . . . 0.0 116.167 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.83 134.87 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.446 1.098 . . . . 0.0 110.476 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.76 167.94 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.96 120.68 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.529 1.932 . . . . 0.0 106.473 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -107.81 -30.16 8.68 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -172.55 146.26 1.69 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.069 1.748 . . . . 0.0 109.98 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.72 153.47 21.33 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.763 1.225 . . . . 0.0 110.475 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.33 136.23 19.24 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -85.32 152.9 10.69 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.296 2.664 . . . . 0.0 114.655 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 7.3 t -78.2 -23.18 47.63 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.206 1.003 . . . . 0.0 112.151 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.68 -171.66 38.12 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 119.535 1.061 . . . . 0.0 112.619 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.07 113.72 3.35 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.85 3.034 . . . . 0.0 112.709 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 m -110.6 140.51 44.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.309 1.444 . . . . 0.0 107.888 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -138.21 -170.1 2.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.513 1.525 . . . . 0.0 109.905 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.549 -1.695 . . . . 0.0 110.926 179.67 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -167.11 134.53 2.45 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.861 1.33 . . . . 0.0 108.409 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -166.42 152.12 8.46 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.081 0.952 . . . . 0.0 108.831 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.05 85.24 0.06 OUTLIER Glycine 0 C--O 1.238 0.359 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.37 99.87 3.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.9 m -72.52 25.98 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.759 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.51 107.36 3.13 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 105.47 -3.052 . . . . 0.0 105.47 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.2 -44.52 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.246 1.018 . . . . 0.0 112.87 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG13 HE21 ' A' ' 10' ' ' GLN . 12.8 p -59.73 -21.97 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.462 HE21 HG13 ' A' ' 9' ' ' VAL . 64.5 mm-40 -70.93 -15.63 62.61 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.352 -0.843 . . . . 0.0 111.246 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.79 143.29 74.58 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.43 163.57 34.17 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.512 1.475 . . . . 0.0 108.379 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' CE1' ' A' ' 19' ' ' TYR . 2.6 tt -53.19 -36.43 60.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.548 0.739 . . . . 0.0 111.58 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -69.04 -9.63 53.48 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -108.29 -2.35 19.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.76 1.224 . . . . 0.0 111.299 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -71.56 157.56 37.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.5 pt? -87.14 -11.43 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.471 1.108 . . . . 0.0 112.625 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.649 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 14.2 p-90 -105.35 4.26 30.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.619 1.568 . . . . 0.0 113.019 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' HD21 ' A' ' 13' ' ' LEU . 37.5 t80 -95.77 83.68 3.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -67.15 -17.89 65.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.97 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -163.01 17.9 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.89 49.08 0.88 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.736 1.768 . . . . 0.0 111.301 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 pt -69.2 148.54 97.55 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.78 155.11 44.03 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.03 2.487 . . . . 0.0 110.068 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -62.77 -23.82 67.41 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.975 -1.078 . . . . 0.0 111.325 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.51 94.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -76.0 -39.25 56.2 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.345 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.79 -44.01 35.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.566 1.146 . . . . 0.0 110.369 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.74 -30.16 42.91 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -81.63 -12.51 58.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.726 0.694 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 107' ' ' VAL . 71.6 mt -81.11 -44.31 18.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -85.97 141.66 29.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.068 0.547 . . . . 0.0 111.857 -177.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -138.57 -30.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.768 1.227 . . . . 0.0 112.202 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.16 158.94 26.88 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.277 0.944 . . . . 0.0 111.659 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -65.9 136.78 56.58 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.33 67.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 117.37 -1.794 . . . . 0.0 111.736 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -70.15 135.26 48.96 Favored 'General case' 0 C--N 1.339 0.112 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 24.7 p90 -144.5 163.61 33.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.123 0.874 . . . . 0.0 112.429 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -159.88 168.59 25.41 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.366 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.71 122.0 48.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.42 146.26 50.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -80.12 155.54 27.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 t -74.17 161.13 30.28 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.286 1.041 . . . . 0.0 109.75 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.82 108.21 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.47 8.89 86.51 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.113 -1.382 . . . . 0.0 115.394 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -141.21 135.2 30.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 120.07 1.935 . . . . 0.0 108.901 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.83 38.15 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.878 1.671 . . . . 0.0 111.148 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.64 112.8 25.08 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.39 -1.444 . . . . 0.0 107.332 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -74.67 149.57 39.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.35 1.071 . . . . 0.0 109.584 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.29 128.37 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.22 1.008 . . . . 0.0 109.393 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.93 140.15 30.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -136.56 126.91 26.58 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.0 158.56 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.4 tp -107.05 137.17 45.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.5 t-105 -155.56 133.91 11.66 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 49.15 42.77 21.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.502 1.144 . . . . 0.0 112.997 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 9.29 54.72 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.225 -1.875 . . . . 0.0 116.473 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.09 120.39 22.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 121.383 2.592 . . . . 0.0 109.263 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.97 99.36 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.2 . . . . 0.0 110.97 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.42 119.29 19.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.829 1.252 . . . . 0.0 108.045 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.61 130.43 38.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.35 114.56 19.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.637 1.175 . . . . 0.0 108.205 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -71.29 132.15 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.2 mt -78.8 123.94 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.8 159.47 34.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -154.98 114.34 3.67 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -147.64 -77.61 0.17 Allowed 'General case' 0 C--O 1.228 -0.038 0 C-N-CA 122.885 0.474 . . . . 0.0 111.718 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' H ' ' CD1' ' A' ' 67' ' ' LEU . 22.9 t0 -73.05 29.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.147 2.579 . . . . 0.0 112.072 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.36 8.72 5.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.312 1.445 . . . . 0.0 110.352 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.53 127.11 46.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.09 2.156 . . . . 0.0 106.306 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 63.6 m-85 -95.94 157.69 15.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 117.551 -1.214 . . . . 0.0 109.748 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 1.2 ptm180 155.63 -154.66 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.557 1 C-N-CA 131.787 4.035 . . . . 0.0 108.987 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.61 -79.51 0.61 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.411 2.684 . . . . 0.0 106.54 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.85 112.1 6.34 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.915 2.086 . . . . 0.0 110.03 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.14 -153.56 23.97 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.717 2.104 . . . . 0.0 109.447 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -73.41 123.58 24.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.703 1.751 . . . . 0.0 108.247 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.19 178.52 34.49 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -140.32 159.6 63.01 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.97 -7.68 17.64 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.544 3.496 . . . . 0.0 114.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.12 161.87 41.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.975 0.807 . . . . 0.0 109.406 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.24 -50.62 58.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.13 -33.28 61.75 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.276 1.849 . . . . 0.0 112.055 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.05 -44.67 83.2 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.611 0.764 . . . . 0.0 108.977 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.6 -47.96 68.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.799 0.44 . . . . 0.0 109.98 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.7 -45.08 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.46 -40.78 83.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.833 0.742 . . . . 0.0 111.204 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -64.0 -44.46 92.57 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.284 0.493 . . . . 0.0 110.864 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.81 -42.71 94.77 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.243 0.929 . . . . 0.0 110.557 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.53 -37.05 85.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.906 1.282 . . . . 0.0 109.219 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 m -75.96 -46.43 29.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.664 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.5 p -81.09 -23.44 38.44 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 63.15 22.11 13.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.564 1.545 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.45 140.29 96.55 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.201 1.0 . . . . 0.0 110.868 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.54 137.85 25.94 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.266 1.311 . . . . 0.0 109.755 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -51.33 -48.14 62.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.585 1.554 . . . . 0.0 109.219 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.1 p -152.63 143.46 22.91 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -21.34 66.41 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.663 -0.648 . . . . 0.0 111.382 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -63.33 -24.13 67.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 117.564 -1.208 . . . . 0.0 113.597 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.1 p -129.22 -14.74 4.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.346 0.976 . . . . 0.0 113.576 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.99 -1.3 3.59 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.122 1.344 . . . . 0.0 115.983 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.79 134.35 16.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 127.495 2.318 . . . . 0.0 112.475 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.81 160.02 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.491 1.916 . . . . 0.0 107.736 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mp -100.75 119.95 39.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.29 1.436 . . . . 0.0 107.797 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -106.36 -35.13 7.23 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.998 0.811 . . . . 0.0 111.642 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -164.77 146.09 7.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.96 0.8 . . . . 0.0 109.435 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -92.03 151.47 20.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 39' ' ' LEU . 9.9 m -87.52 122.24 70.69 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.42 131.44 17.6 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.215 1.944 . . . . 0.0 111.651 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.7 p -65.99 -41.67 90.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.739 0.816 . . . . 0.0 111.843 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.33 -179.53 31.26 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.745 0.688 . . . . 0.0 111.486 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.6 -5.67 8.08 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.707 3.605 . . . . 0.0 112.627 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -76.1 127.46 32.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.464 1.106 . . . . 0.0 110.762 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 p -168.08 124.81 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.48 13.74 6.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.738 1.615 . . . . 0.0 113.644 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -131.44 107.72 9.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.79 2.76 0.03 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.91 -1.495 . . . . 0.0 115.171 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 m -57.48 105.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.897 1.849 . . . . 0.0 110.909 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -172.36 158.37 4.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.451 1.5 . . . . 0.0 108.183 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.09 25.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 105.638 -2.985 . . . . 0.0 105.638 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.57 -36.84 43.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.11 -37.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.935 1.694 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -70.93 -11.7 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.24 1.016 . . . . 0.0 112.568 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -90.92 146.06 33.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.9 169.9 19.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.736 1.624 . . . . 0.0 108.437 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.83 -33.66 56.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.151 0.581 . . . . 0.0 112.365 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -11.63 51.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.152 1.381 . . . . 0.0 112.943 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.0 14.77 17.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.008 1.723 . . . . 0.0 110.564 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -96.48 141.99 29.1 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.303 1.041 . . . . 0.0 112.686 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.05 -21.52 65.9 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.25 1.42 . . . . 0.0 113.584 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.4 p-90 -96.78 0.14 48.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.365 1.066 . . . . 0.0 113.59 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -92.91 92.32 7.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -66.1 -52.56 47.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.511 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.6 -156.99 25.57 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.27 18.96 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 113.092 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.8 144.99 79.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.91 1.284 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -83.9 173.82 8.91 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.634 2.889 . . . . 0.0 113.605 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -58.35 -29.31 65.87 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.311 1.044 . . . . 0.0 109.608 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -4.47 2.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.569 1.948 . . . . 0.0 113.091 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -124.65 -44.58 1.96 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.887 1.675 . . . . 0.0 107.086 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' HD12 ' A' ' 32' ' ' LEU . 85.6 t -53.79 -51.71 41.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 123.318 0.647 . . . . 0.0 109.333 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -16.99 10.88 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.04 -29.35 18.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.902 0.774 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 mt -73.05 -47.26 46.3 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.841 1.656 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 28' ' ' VAL . 2.8 mp -74.85 129.02 36.94 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -129.68 -26.55 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 118.513 0.597 . . . . 0.0 111.395 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -124.55 150.1 46.25 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.846 0.748 . . . . 0.0 112.409 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.3 m -61.14 132.71 54.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 -16.7 49.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.174 -1.348 . . . . 0.0 110.65 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -68.75 128.35 36.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 106' ' ' ALA . 22.3 p90 -132.16 157.89 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 109.386 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -158.3 167.99 28.24 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.158 1.783 . . . . 0.0 107.508 178.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.32 134.62 63.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -138.96 159.35 42.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -103.4 147.74 26.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -68.63 -170.09 0.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.854 1.261 . . . . 0.0 112.046 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -108.93 137.61 46.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.89 -75.67 1.84 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.91 136.02 35.99 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.86 77.27 9.62 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -114.48 122.77 47.61 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.19 1.396 . . . . 0.0 108.278 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -79.08 150.82 31.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.013 0.911 . . . . 0.0 108.761 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.34 132.66 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.054 0.941 . . . . 0.0 108.49 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.68 98.56 9.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.0 m -98.23 126.36 43.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -130.02 159.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.15 142.68 39.58 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -165.91 147.17 6.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 50.63 27.66 3.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.79 15.08 68.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 113.332 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -122.47 110.37 32.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.35 1.86 . . . . 0.0 109.491 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.35 94.45 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.649 2.233 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -69.42 117.56 11.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.691 1.996 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -92.67 122.75 35.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.97 108.21 15.0 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.0 mp -66.1 125.71 23.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.049 1.34 . . . . 0.0 107.686 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.9 mt -76.47 115.9 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -86.32 144.32 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 108.834 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 p -127.0 107.0 9.67 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.123 1.769 . . . . 0.0 108.012 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.49 HD11 ' HE ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -131.48 -78.7 0.52 Allowed 'General case' 0 C--O 1.231 0.106 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -81.43 35.68 0.4 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.836 1.198 . . . . 0.0 113.35 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.41 23.54 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.886 1.326 . . . . 0.0 110.65 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -139.15 141.66 38.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.212 3.005 . . . . 0.0 103.528 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -100.86 139.93 35.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HE ' HD11 ' A' ' 67' ' ' LEU . 22.7 ptt85 -157.82 169.42 24.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.213 1.005 . . . . 0.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.56 -66.96 1.0 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 112.542 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -138.9 33.7 2.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.915 1.686 . . . . 0.0 110.448 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.83 -155.28 11.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.81 167.04 2.99 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.38 1.472 . . . . 0.0 110.438 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -131.55 -174.43 13.65 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -148.39 161.41 33.91 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 109.273 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.52 -9.65 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.934 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -149.27 158.41 44.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.029 1.286 . . . . 0.0 109.832 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 81' ' ' ILE . 4.5 mp -60.82 -51.03 82.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 117.199 -1.382 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.95 -34.57 95.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.414 1.541 . . . . 0.0 113.292 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.54 -41.86 95.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.8 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.07 -45.79 39.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.339 0.656 . . . . 0.0 109.39 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.42 -42.92 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -45.98 88.09 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.745 1.218 . . . . 0.0 110.308 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -60.87 -44.88 96.46 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.5 -49.92 71.68 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 118.835 0.743 . . . . 0.0 111.156 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.71 -44.8 86.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.34 1.056 . . . . 0.0 109.114 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 t -66.62 -62.38 1.48 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.375 -0.828 . . . . 0.0 111.698 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.4 p -67.85 -19.08 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 61.84 24.85 14.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.761 1.224 . . . . 0.0 110.923 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.37 149.71 97.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.472 -0.767 . . . . 0.0 110.149 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -80.07 133.75 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 N-CA-C 106.778 -2.047 . . . . 0.0 106.778 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -46.09 -39.43 9.35 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.812 2.045 . . . . 0.0 115.116 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.6 p -144.64 135.93 25.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -39.26 -51.92 1.99 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.91 2.084 . . . . 0.0 114.967 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -65.36 -30.67 71.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.531 0.605 . . . . 0.0 112.611 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.78 173.58 9.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 123.562 1.649 . . . . 0.0 111.896 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.39 10.95 7.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.619 2.056 . . . . 0.0 110.31 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -72.27 125.88 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.419 1.887 . . . . 0.0 110.322 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.41 154.89 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 108.741 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.71 127.94 34.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -121.15 -36.26 3.15 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.031 0.832 . . . . 0.0 110.569 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -156.31 136.32 12.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.417 1.008 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . . . -85.44 132.7 34.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -79.78 118.48 72.66 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 120.503 1.502 . . . . 0.0 107.121 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.27 136.29 21.83 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.263 1.975 . . . . 0.0 111.674 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -75.29 -15.47 60.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.473 1.109 . . . . 0.0 112.445 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.04 -163.12 38.37 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.89 0.768 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.78 84.52 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.436 2.758 . . . . 0.0 108.894 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -149.31 146.87 27.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.142 0.496 . . . . 0.0 110.946 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 p -138.82 -15.1 1.18 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.856 2.062 . . . . 0.0 109.776 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 -179.627 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.352 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 p -94.46 -11.65 29.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.113 0.957 . . . . 0.0 110.813 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -70.47 154.53 41.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.301 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 170.47 25.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.93 44.06 1.93 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 126.903 2.081 . . . . 0.0 107.711 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -61.87 -18.66 60.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.88 83.75 0.05 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.567 1.531 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 pm0 -85.64 -39.75 16.95 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.126 1.77 . . . . 0.0 109.101 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.2 -23.53 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 110.642 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.71 -29.51 67.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.272 1.029 . . . . 0.0 110.984 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -72.3 142.11 84.15 Favored Pre-proline 0 CA--C 1.517 -0.316 0 C-N-CA 123.558 0.743 . . . . 0.0 109.792 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.88 161.71 44.5 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 N-CA-C 106.414 -2.187 . . . . 0.0 106.414 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -46.82 -36.16 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 113.186 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -57.78 -21.56 42.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.36 5.63 16.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.715 1.143 . . . . 0.0 111.77 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -73.6 139.17 45.35 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.55 -17.07 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.916 1.686 . . . . 0.0 113.615 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -98.28 -1.23 42.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 112.289 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CE1' HD21 ' A' ' 13' ' ' LEU . 38.2 t80 -88.57 85.63 6.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.902 -1.124 . . . . 0.0 108.34 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -73.96 -45.62 49.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.09 -168.11 24.14 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 119.104 0.866 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.79 41.14 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.997 1.319 . . . . 0.0 111.578 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 pt -70.75 138.17 85.6 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.532 1.133 . . . . 0.0 112.257 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.36 178.01 7.56 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.735 2.957 . . . . 0.0 111.477 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -23.36 63.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.72 94.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 123.782 0.677 . . . . 0.0 110.45 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.69 -49.99 8.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 123.453 0.47 . . . . 0.0 110.671 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.5 t -46.4 -42.69 5.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.541 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.53 48.93 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.61 -20.57 21.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.242 1.383 . . . . 0.0 112.906 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.11 -48.62 80.81 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.097 0.959 . . . . 0.0 109.655 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.02 127.05 35.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.32 -35.79 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.468 0.707 . . . . 0.0 109.101 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 147.56 33.6 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.333 -0.854 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -61.82 141.08 58.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.46 68.25 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.039 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -69.5 134.02 48.4 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -140.0 160.44 39.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.841 0.856 . . . . 0.0 111.876 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.06 162.43 34.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.255 2.222 . . . . 0.0 110.17 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.38 137.56 50.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 120.373 -1.454 . . . . 0.0 108.29 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -131.08 153.38 49.39 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.018 0.927 . . . . 0.0 108.744 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.58 148.88 21.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 t -77.84 118.01 19.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -47.78 106.08 0.08 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.423 1.889 . . . . 0.0 113.759 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.08 35.58 26.96 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 123.805 0.716 . . . . 0.0 112.887 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -155.42 170.69 21.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.937 1.695 . . . . 0.0 106.569 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -119.51 68.98 0.82 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -150.02 121.67 8.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -82.31 166.23 19.68 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.074 0.94 . . . . 0.0 112.529 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.8 t -140.26 133.98 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.501 2.321 . . . . 0.0 107.927 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.05 93.05 4.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 107.381 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -89.31 117.11 28.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.03 0.932 . . . . 0.0 108.704 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.65 151.62 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.5 tp -94.64 135.87 35.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.287 0.949 . . . . 0.0 109.366 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -156.92 135.21 11.28 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 49.73 46.71 23.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.111 0.957 . . . . 0.0 109.635 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.63 8.5 27.08 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.419 1.485 . . . . 0.0 116.364 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tt -125.24 125.44 25.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 120.1 1.95 . . . . 0.0 111.159 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.14 101.41 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.401 2.734 . . . . 0.0 109.575 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -75.22 115.29 14.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.285 2.234 . . . . 0.0 108.757 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.3 108.86 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.34 117.85 35.43 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.66 124.67 35.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.68 140.65 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -103.0 140.68 36.95 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -143.59 98.92 3.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 mt -132.61 -57.66 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.424 0.63 . . . . 0.0 111.799 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.5 14.59 3.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 127.788 2.435 . . . . 0.0 112.415 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 t30 65.82 13.28 8.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.029 1.732 . . . . 0.0 111.073 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.31 103.34 6.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -65.91 129.48 39.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -157.22 167.77 29.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.725 1.61 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 -39.18 0.83 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.796 0.439 . . . . 0.0 111.791 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -136.13 -53.8 0.75 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.65 0.78 . . . . 0.0 109.484 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.55 25.09 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.755 1.645 . . . . 0.0 111.598 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -67.27 172.74 4.47 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -125.32 179.93 15.98 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.1 158.44 67.02 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.38 -10.74 19.79 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.691 3.594 . . . . 0.0 115.098 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.83 156.95 42.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.89 -50.36 85.3 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 116.809 -1.567 . . . . 0.0 110.439 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.46 -34.38 93.03 Favored 'Trans proline' 0 C--N 1.354 0.855 0 CA-C-N 121.779 1.671 . . . . 0.0 112.464 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.3 -38.58 80.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.51 0.595 . . . . 0.0 110.106 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.34 -46.71 26.33 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.592 1.157 . . . . 0.0 108.862 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -54.08 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.773 0.715 . . . . 0.0 109.212 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.11 -37.92 67.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 110.716 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.0 -47.9 78.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.12 -0.987 . . . . 0.0 109.792 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.42 -40.02 92.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.145 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -76.63 -45.32 30.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.375 0.988 . . . . 0.0 111.662 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.8 p -74.53 -26.08 59.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.24 22.58 12.9 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.9 1.28 . . . . 0.0 110.522 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.49 144.0 98.83 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 123.499 0.72 . . . . 0.0 109.611 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.57 131.33 11.37 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.217 1.278 . . . . 0.0 109.695 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mt -48.64 -45.43 38.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.823 2.449 . . . . 0.0 110.783 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.9 p -152.62 154.3 35.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -39.34 61.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.468 0.577 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.87 -21.96 22.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -125.86 -33.6 2.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.345 0.658 . . . . 0.0 110.063 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.52 14.15 81.29 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.112 -1.382 . . . . 0.0 113.732 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.55 140.41 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.13 1.465 . . . . 0.0 111.392 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.1 t -133.85 148.64 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.66 112.92 24.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -86.68 -46.37 10.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.687 -0.673 . . . . 0.0 109.936 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -164.49 154.76 14.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.388 0.994 . . . . 0.0 111.273 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.49 163.11 26.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 111.278 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.36 113.39 62.02 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 101.424 -3.547 . . . . 0.0 101.424 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 128.36 10.49 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.563 2.175 . . . . 0.0 111.703 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -68.2 -36.75 80.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.674 0.75 . . . . 0.0 110.789 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.11 179.83 48.24 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.43 1.014 . . . . 0.0 111.203 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.58 -14.06 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.282 2.655 . . . . 0.0 113.85 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -137.5 153.68 50.0 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 p -141.39 -178.45 5.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.153 1.781 . . . . 0.0 110.801 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 125.962 1.744 . . . . 0.0 109.763 179.828 . . . . . . . . 0 0 . 1 stop_ save_